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Marijuana Edibles and “Gummy Bears” 
PAUL J. LARKIN, JR.† 
 
For most of the last eighty years, state and federal law,1 
along with international agreements to which the United 
States is a signatory,2 have outlawed the cultivation, 
distribution, and possession of marijuana, occasionally 
punishing such conduct quite severely.3 Over the last two 
 
† Senior Legal Research Fellow, The Heritage Foundation; M.P.P. George 
Washington University, 2010; J.D., Stanford Law School, 1980; B.A., Washington 
& Lee University, 1977. The views expressed in this Article are my own and 
should not be construed as representing any official position of The Heritage 
Foundation. I thank Lawrence A. Brett, Dr. Robert L. DuPont, David Evans, 
Calvin Fay, Ed Haislmaier, Mark A.R. Kleiman, Bertha K. Madras, John 
Malcolm, Kevin Sabet, Charles Stimson, and Amy Swearer for excellent 
comments on an earlier version of this Article. I also thank Lawrence A. Brett 
and Claudia Rychlik for outstanding research assistance. Any errors are mine. 
 1. See, e.g., RICHARD J. BONNIE & CHARLES H. WHITEBREAD II, THE 
MARIJUANA CONVICTION: A HISTORY OF MARIJUANA PROHIBITION IN THE UNITED 
STATES (Lindesmith Ctr. 1999) (1974). 
 2. See Single Convention on Narcotic Drugs, Mar. 30, 1961, 18 U.S.T. 1407, 
amended by 1972 Protocol, Mar. 25, 1972, 26 U.S.T. 1439; Convention on 
Psychotropic Substances, Feb. 21, 1971, 32 U.S.T. 543; United Nations 
Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances, Dec. 20, 1988, 1582 U.N.T.S. 164; ROBIN ROOM ET AL., CANNABIS 
POLICY: MOVING BEYOND STALEMATE 3, 7–8, 75–76 (2010). 
 3. See Hutto v. Davis, 454 U.S. 370, 371, 375 (1982) (rejecting the claim that 
a forty-year sentence for possessing nine ounces of marijuana with the intent to 
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decades, however, numerous states have revised their state 
constitutions or criminal codes to permit marijuana use by 
adults for medical or recreational purposes.4 Those 
developments have led to a variety of novel issues that could 
not have arisen when marijuana was deemed contraband 
and was grown and sold in a sub-rosa manner.5 The ongoing 
 
distribute it was an unconstitutional cruel and unusual punishment). 
 4. Since 1996, twenty-nine states and the District of Columbia revised their 
laws to permit medicinal use of cannabis. State Medical Marijuana Laws, NAT’L 
CONF. ST. LEGISLATURES (Feb. 15, 2018), http://www.ncsl.org/research/health/
state-medical-marijuana-laws.aspx. There is considerable regulatory variation 
among those states. See, e.g., Rosalie L. Pacula et al., Words Can Be Deceiving: A 
Review of Variation Among Legally Effective Medical Marijuana Laws in the 
United States, 7 J. DRUG POL’Y ANALYSIS 1 (2014). The California law is so open-
ended and has been so broadly applied that it was tantamount to a recreational-
use law. See CAL. HEALTH & SAFETY CODE § 11362.5 (West 2014) (authorizing 
marijuana to be used for treatment of “cancer, anorexia, AIDS, chronic pain, 
spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana 
provides relief”) (emphasis added); Paul J. Larkin, Jr., Medical or Recreational 
Marijuana and Drugged Driving, 52 AM. CRIM. L. REV. 453, 510–12 (2015) 
[hereinafter Larkin, Drugged Driving]; cf. Deepak Cyril D’Souza & Mohini 
Ranganathan, Editorial, Medical Marijuana: Is the Cart Before the Horse?, 313 
JAMA 2431, 2431 (2015) (questioning why states authorize medical marijuana 
for diseases such as psoriasis). Beginning in 2012, eight of those states and the 
District of Columbia have gone further by legalizing the possession and 
recreational use of small amounts of marijuana. For example, in the fall of 2016 
California voters passed Proposition 64, which legalized the sale, possession, and 
use of marijuana for recreational purposes and empowered the state to regulate 
that business. Vermont will join that club on July 1, 2018, when a new state law 
goes into effect permitting recreational marijuana use, albeit without large-scale 
commercialization. Magdalena Cerdá et al., Association of State Recreational 
Marijuana Laws with Adolescent Marijuana Use, 171 JAMA PEDIATRICS 142, 143 
(2017); Michael R. Blood & Julie Watson, California Issues 1st Licenses for Legal 
Pot Market, U.S. NEWS & WORLD REP. (Dec. 15, 2017, 8:34 AM), 
https://www.usnews.com/news/best-states/california/articles/2017-12-15/californ
ia-issues-1st-licenses-for-legal-pot-market; Chantal Da Silva, Vermont Becomes 
Ninth State to Legalize Marijuana, But Getting Pot Might Be Tricky, NEWSWEEK 
(Jan. 23, 2018), http://www.newsweek.com/vermont-becomes-ninth-state-
legalize-marijuana-heres-where-buy-it-787792. 
 5. For a sample of recently published scientific, professional, and popular 
books and papers discussing those issues (in addition to the literature cited 
elsewhere in this Article), see NAT’L HIGHWAY SAFETY ADMIN., U.S. DEP’T OF 
TRANSP., DOT HS 812 440, MARIJUANA-IMPAIRED DRIVING: A REPORT TO CONGRESS 
(2017); NAT’L ACAD. SCI., ENG’G, & MED., THE HEALTH EFFECTS OF CANNABIS AND 
CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND RECOMMENDATIONS FOR 
RESEARCH (2017) [hereinafter NAT’L ACAD. REP.]; OFF. OF NAT’L DRUG CONTROL 
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debate over marijuana policy has generated considerable 
disagreement over a host of issues,6 particularly over the 
treatment of marijuana under the state liberalization 
initiatives as a legitimate article of trade or medicine, even 
though it remains contraband under federal law.7 
One point on which everyone has agreed is that 
marijuana should not be peddled to children.8 Perhaps that 
 
POLICY, MARIJUANA MYTHS AND FACTS: THE TRUTH BEHIND 10 POPULAR 
MISCONCEPTIONS (2014), http://www.nationaldec.org/goopages/pages_download
gallery/download.php?filename=19411.pdf&orig_name=418.pdf; WILLIAM J. 
BENNETT & ROBERT A. WHITE, GOING TO POT: WHY THE RUSH TO LEGALIZE 
MARIJUANA IS HARMING AMERICA (2015); JONATHAN P. CAULKINS ET AL., 
MARIJUANA LEGALIZATION: WHAT EVERYONE NEEDS TO KNOW (2d ed. 2016) 
[hereinafter CAULKINS ET AL., MARIJUANA LEGALIZATION]; KEVIN A. SABET, REEFER 
SANITY: SEVEN GREAT MYTHS ABOUT MARIJUANA (2d ed. 2018); Laura Amato et al., 
Systematic Review of Safeness and Therapeutic Efficacy of Cannabis in Patients 
with Multiple Sclerosis, Neuropathic Pain, and in Oncological Patients Treated 
with Chemotherapy, 41 EPIDEMIOLOGY PREV. 279 (2017); Marcus A. Bachhuber et 
al., Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the 
United States, 1999–2010, 174 JAMA INTERNAL MED. 1668 (2014); Alain Braillon, 
Low-Risk Cannabis Use Is an Oxymoron, 107 AM. J. PUB. HEALTH e26 (2017); 
June H. Kim et al., State Medical Marijuana Laws and the Prevalence of Opioids 
Detected Among Fatally Injured Drivers, 106 AM. J. PUB. HEALTH 2032 (2016); 
Melvin D. Livingston et al., Recreational Cannabis Legalization and Opioid-
Related Deaths in Colorado, 2000–2015, 107 AM. J. PUB. HEALTH 1827 (2017); 
Andrew A. Monte et al., The Implications of Marijuana Legalization in Colorado, 
313 JAMA 241 (2015); David L. Nathan et al., The Physicians’ Case for Marijuana 
Legalization, 107 AM. J. PUB. HEALTH 1746 (2017). 
 6. See, e.g., W. Hall & M. Weier, Assessing the Public Health Impacts of 
Legalizing Recreational Cannabis Use in the USA, 97 CLINICAL PHARMACOLOGY 
607 (2015); Angela Hawken et al., Editorial, Quasi-Legal Cannabis in Colorado 
and Washington: Local and National Implications, 108 ADDICTION 837 (2013); 
Todd Subritzky et al., Issues in the Implementation and Evolution of the 
Commercial Recreational Cannabis Market in Colorado, 27 INT’L J. DRUG POL’Y 1 
(2016); see generally Paul J. Larkin, Jr., Introduction to a Debate: “Marijuana: 
Legalize, Decriminalize, or Leave the Status Quo in Place?,” 23 BERKELEY J. CRIM. 
L. (forthcoming 2018) (summarizing the arguments on each side) [hereinafter 
Larkin, Marijuana Debate]. 
 7. See, e.g., Gonzales v. Raich, 545 U.S. 1, 32–33 (2005) (upholding 
Congress’s Commerce Clause authority to prohibit the local cultivation and use 
of marijuana in compliance with state law); United States v. Oakland Cannabis 
Buyers’ Coop., 532 U.S. 483, 494–95 (2001) (holding that medical necessity is not 
a defense under federal law to a charge of unlawfully distributing marijuana). 
 8. See THOMAS BABOR ET AL., DRUG POLICY AND THE PUBLIC GOOD 105 (2010) 
(“Preventing people from becoming illicit drug users is a broadly shared goal 
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is because the supporters of marijuana liberalization believe 
that arguing for marijuana to be treated in the same manner 
as alcohol—viz., lawfully sold but regulated—is an easier 
political sell than complete legalization. Perhaps that is 
because proponents of liberalization know that the political 
blowback from any proposal that would allow minors free 
access to marijuana would sink their efforts to legalize adult 
marijuana use. Or perhaps it is because of something else 
entirely. Regardless, despite the well-known adage that 
advocates for any principle tend to push it to the extreme 
limit of its logic,9 no one argues today that minors should be 
free to use marijuana in the same manner as adults. Even 
states that allow marijuana to be sold to adults for 
recreational purposes deny minors that privilege.10 
The problem arises of how to police that judgment with 
respect to a variety of different commercial food products, 
colloquially known as “edibles.” They are designed to be 
eaten and often resemble food products that anyone, 
including minors, would consume. Edibles allow individuals 
to obtain the psychoactive benefits of using marijuana 
 
among policymakers. When focused on young people, prevention programmes 
enjoy broad popular support as well.”); e.g., COLO. CONST. art. XVIII, § 16(1)(a), 
(2)(b), (3), (4) (creating a state constitutional right for only adults to use 
marijuana for recreational purposes); COLO. REV. STAT. § 18-18-406 (2017); 1 
COLO. CODE REGS. § 212-2.402(A) (2017) (“Licensees are prohibited from 
transferring, giving, or distributing Retail Marijuana, Retail Marijuana 
Concentrate, or Retail Marijuana Product to persons under 21 years of age.”); 
WASH. REV. CODE § 69.50.360(3) (2017); WASH ADMIN. CODE § 314-55-095(1) 
(2017). Medical and recreational uses of marijuana raise distinct concerns. See, 
e.g., COLO. CONST. art. XVIII, § 16(7) (stating that recreational marijuana 
amendment does not limit the rights of a medical marijuana patient); id. art. 
XVIII, § 14(6) (creating special rules for medical marijuana use by minors). No 
state that has permitted marijuana to be used recreationally—Alaska, California, 
Colorado, Maine, Massachusetts, Nevada, Oregon, Vermont, and Washington 
(along with the District of Columbia)—permits cannabis to be distributed to 
minors for recreational use. See Robert J. MacCoun & Michelle M. Mello, Half-
Baked—The Retail Promotion of Marijuana Edibles, 372 N. ENG. J. MED. 989, 
989–90 (2015). 
 9. See Hein v. Freedom from Religion Found., 551 U.S. 587, 615 (2007) (lead 
opinion). 
 10. Cerdá et al., supra note 4, at 143. 
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without inhaling carcinogens.11 Edibles have two other 
attractive features as well: they can contain a heavy dose of 
sugar, making them enticing for people with a sweet tooth, 
and they avoid the tell-tale aroma of smoked marijuana, 
making them attractive for minors trying to avoid detection 
by their parents. 
Selling edibles poses the risk that children will find and 
mistakenly consume a product that injures them and that 
adolescents will find and intentionally consume the same 
product. How do we prevent those results? Who should make 
that decision—the local, state, or federal governments? Will 
the method selected to prevent those harms infringe on the 
ability of adults to purchase the same delivery mechanism? 
If so, does that matter? 
This Article will discuss one of those issues: namely, 
whether the Food and Drug Administration (FDA) should 
intervene and regulate the sale of edible forms of marijuana 
to prevent the risk that children who happen upon their 
parents’ “stash” will unwittingly consume it, believing that it 
is a traditional form of candy, or that adolescents will 
knowingly consume it, hoping for its psychoactive effects. 
Part I will discuss the retail distribution of marijuana in 
edible forms. Part II will identify the potential harms that 
minors can suffer from the consumption of marijuana, 
regardless of its form. It also explains the particular harms 
that can result from distributing food containing 
cannabinoids, the psychoactive ingredients in marijuana, 
 
 11. See, e.g., ROBERT L. DUPONT, THE SELFISH BRAIN: LEARNING FROM 
ADDICTION 156 (1997) (“Marijuana smoke contains more tar and cancer-causing 
chemicals than even cigarette smoke. One marijuana cigarette has as much 
cancer-causing tar as 17 tobacco cigarettes. Marijuana smoke, like tobacco 
smoke, causes bronchitis, inflammation of the airways in the lings, and chronic 
respiratory illnesses.”); GEORGE F. KOOB ET AL., DRUGS, ADDICTION, AND THE BRAIN 
306 (2014) (“Marijuana smoke may also have the same potential toxicity as 
cigarette smoke with regard to lung function.”); Daniel G. Barrus et al., Tasty 
THC: Promises and Challenges of Cannabis Edibles, RTI PRESS 2, 4 (Nov. 2016) 
(stating that anecdotal consumer reports attribute interest in edibles to the 
ability to use them discretely, their more relaxing state of intoxication they 
provide, and the ability to avoid toxins and health risks). 
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principally one known by the acronym THC.12 Part III then 
discusses the options available to the local, state, and federal 
governments, particularly to the U.S. Food and Drug 
Administration, to prevent minors from suffering those 
harms by prohibiting the distribution of marijuana edibles 
that could be mistaken for candy or some other treat that a 
minor could eat. 
I. THE DISTRIBUTION OF MARIJUANA IN EDIBLE FORM 
Legalization initiatives have led to the sale of marijuana 
by private parties from brick-and-mortar buildings called 
“dispensaries” when marijuana is sold for medical use.13 
Those businesses sell marijuana in the traditional dried 
plant form of leaves and flowers that can be smoked in 
cigarettes, cigars, pipes, water pipes, and “blunts” 
(marijuana wrapped in tobacco leaves), or, using today’s new 
technology, vaporized and inhaled (or, to use the vernacular, 
“vaped”). The psychoactive component of marijuana, THC, 
also comes in the form of oil or concentrates. Another popular 
medium is commercial food products, known as “edibles.” 
Food is rarely used as the delivery system for drugs, 
 
 12. DUPONT, supra note 11, at 154–55; LESLIE L. IVERSEN, THE SCIENCE OF 
MARIJUANA 35 (2d ed. 2008); Harold Kalant, Effects of Cannabis and 
Cannabinoids in the Human Nervous System, in THE EFFECTS OF DRUG ABUSE ON 
THE HUMAN NERVOUS SYSTEM 387, 387 (Bertha Madras & Michael Kuhar eds., 
2014). The technical name for THC is Δ9-tetrahydrocannabinol. The chemical 
structure of THC closely resembles that of anandamide, an endogenously 
produced cannabinoid, named after the Sanskrit term “ananda,” which means 
“bliss.” See Bertha Madras, Drug Use and Its Consequences, in THE EFFECTS OF 
DRUG ABUSE ON THE HUMAN NERVOUS SYSTEM, supra, at 11; Maximilian Peters & 
Raphael Mechoulam, The Endocannabinoid System, in 2 PROFESSIONAL 
PERSPECTIVES ON ADDICTION MEDICINE 31, 34–36 (Mark Sanford & Donald Avoy 
eds., 2009). 
 13. As of September 2015, there were 385 licensed retail stores, 496 licensed 
marijuana cultivators, and 141 licensed infused product manufacturers in 
Colorado. Subritzky et al., supra note 6, at 1. One Arizona business has a drive-
thru. Marcella Baietto, Arizona’s First Medical Marijuana Drive-Thru Now Open, 
AZ CENTRAL (Oct. 28, 2017), https://www.azcentral.com/story/news/nation-
now/2017/10/28/arizonas-first-medical-marijuana-drive-thru-now-open/8096110
01/. 
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including controlled substances.14 Edibles, however, serve in 
that role. Those foods come in different forms, such as 
cookies, candies, cakes, popcorn products, lozenges, 
chocolates, butter, popsicles, and liquids,15 as well as the 
Alice B. Toklas brownies made popular in the 1960s.16 As one 
observer noted, “[e]ssentially, a cannabis culinary 
professional can infuse just about anything you want to eat 
with THC . . . .”17 
Edibles, it seems, are quite popular among marijuana’s 
consumers.18 One estimate is that between eleven and 
twenty-six percent of people who have used marijuana 
 
 14. Buprenorphine (a drug that avoids the psychoactive effects of opiates and 
the discomfort of withdrawal) and naloxone (an opiate antagonist) are delivered 
in sublingual strips, nicotine and aspirin are delivered in gum, and a few other 
drugs come in a similar form. George S. Wang et al., Association of Unintentional 
Pediatric Exposures with Decriminalization of Marijuana in the United States, 
63 ANNALS OF EMERGENCY MED. 684, 688 (2014) [hereinafter Wang et al., 
Multistate Study 2005–2011]. No FDA-approved medication is smoked. Herbert 
D. Kleber & Robert L. DuPont, Physicians and Medical Marijuana, 169 AM. J. 
PSYCHIATRY 564, 564 (2012). 
 15. See, e.g., 1 COLO. CODE REGS. § 212-2.103 (2017) (“‘Edible Retail Marijuana 
Product’ means any Retail Marijuana Product for which the intended use is oral 
consumption, including but not limited to, any type of food, drink, or pill.”); JOHN 
HUDAK, MARIJUANA: A SHORT HISTORY 17–18 (2016) (noting that edibles come in 
“countless forms including cookies, brownies, candies, granola, salad dressing, 
and even pasta sauce.”); Katherine M. Kosa et al., Consumer Use and 
Understanding of Labeling of Information on Edible Marijuana Products Sold for 
Recreational Use in the States of Colorado and Washington, 43 INT’L J. DRUG 
POL’Y 57, 57 (2017); MacCoun & Mello, supra note 8, at 989–90; George Sam 
Wang et al., Unintentional Pediatric Exposures to Marijuana in Colorado, 2009–
2015, 170 JAMA PEDIATRICS 1, 2 (2016) [hereinafter Wang et al., Colorado Study 
2009–2015]; Jennifer Maloney & David-George-Cosh, Big Brewer Makes a Play 
for Marijuana Beverages, WALL ST. J. (Oct. 27, 2017), https://www.wsj.com/
articles/big-brewer-makes-a-play-for-marijuana-beverages-1509300002?mod=m
ktw&mg=prod/accounts-wsj. 
 16. Inspired by I LOVE YOU, ALICE B. TOKLAS (Warner Bros.-Seven Arts 1968). 
Toklas was a real-life writer whose cookbook had a recipe for marijuana brownies. 
 17. HUDAK, supra note 15, at 20; id. at 18 (“The variety now available is a real 
testament to American entrepreneurship and innovation.”). 
 18. A 2015 estimate was that sixteen to twenty-six percent of patients using 
medical cannabis consume edible products. Ryan Vandrey, et al., Cannabinoid 
Dose and Label Accuracy in Edible Medical Cannabis Products, 313 JAMA 2491, 
2491 (2015). 
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medicinally have consumed edibles.19 Approximately five 
million units of edible products were sold in Colorado in 
2014, the first year of recreational marijuana sales; one 
company alone produced 40,000 THC-infused candy bars per 
month.20 All told, edibles constituted forty-five percent of the 
$573 million in revenue generated by legal cannabis sales in 
Colorado and forty percent—more than 570,000 units—of 
marijuana sales in Washington.21 
The pharmacokinetics—the action of the body on a drug, 
viz., metabolism, distribution, and elimination—of 
inhalation and ingestion differ materially from each other. 
Inhaling marijuana quickly distributes THC to the brain by 
entering the circulatory system in the lungs, providing the 
user with the hoped-for psychoactive effect without delay. By 
contrast, ingesting marijuana through an edible takes far 
longer to achieve that effect because the food must be 
digested and pass through the liver, which metabolizes much 
of the THC, before it becomes available to the brain.22 As a 
result, someone unfamiliar with the pharmacokinetics of 
marijuana, such as a minor or first-time user, or someone 
who travels to a state with liberal marijuana laws for the 
purpose of trying out cannabis, a so-called “marijuana 
tourist,” might overconsume the amount of THC-laced food 
necessary to receive the effect and, instead, wind up with a 
very unpleasant experience and a trip to the emergency 
 
 19. Barrus et al., supra note 11, at 2. 
 20. Id.; Kosa et al., supra note 15, at 57; Subritzky et al., supra note 6, at 3; 
see also Jane A. Allen et al., New Product Trial, Use of Edibles, and Unexpected 
Highs Among Marijuana and Hashish Users in Colorado, 176 DRUG & ALCOHOL 
DEPENDENCE 44, 46 (2017) (noting that in Colorado in 2014, more than seventy 
percent of a sample of past-year marijuana and hashish users tried a new product 
and half of them consumed an edible). 
 21. Barrus et al., supra note 11, at 2; Kosa et al., supra note 15, at 57; Wang 
et al., Colorado Study 2009–2015, supra note 15, at 2. 
 22. IVERSEN, supra note 12, at 41–47, 129; Barrus et al., supra note 11, at 3–
5; NAT’L INST. ON DRUG ABUSE, MARIJUANA 2–3 (Aug. 2017) [hereinafter NAT’L 
INST., MARIJUANA]. 
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room.23 
Inhaled and edible versions of marijuana have another 
important difference, too. Businesses have developed edibles 
that resemble the traditional candies attractive to children. 
Some edibles resemble “Gummy Bears,” while others have 
been labeled as “Pot Tarts,” “Buddahfinger,” “Munchy Way,” 
or Keef Kat.”24 That clever—perhaps too clever—marketing 
strategy raises a serious medical and public policy issue 
because THC produces harmful effects in minors that do not 
occur in adults due to the materially different stages of 
neurological development for the two groups. This presents 
state and federal governments with a legal problem that did 
 
 23. MacCoun & Mello, supra note 8, at 989–90. That may be what happened 
to Maureen Dowd when she ate a THC-laced candy bar in Colorado. Maureen 
Dowd, Don’t Harsh Our Mellow, Dude, N.Y. TIMES (June 3, 2014), 
https://www.nytimes.com/2014/06/04/opinion/dowd-dont-harsh-our-mellow-dude
.html; see also HUDAK, supra note 15, at 17 (discussing what has been called the 
“Maureen Dowd Effect”); Allen et al., supra note 20, at 46; Barrus et al., supra 
note 11, at 5 (noting that 65 percent of edible users have an adverse experience 
and that “[t]he lack of consistency and the delayed intoxication may cause both 
new and experienced users of cannabis to consume higher than intended amounts 
of the drug. Edible products are responsible for the majority of health care visits 
due to cannabis intoxication, which is likely due to the failure of users to 
appreciate the delayed effects.”). 
 24. See Barrus et al., supra note 11, at 6; MacCoun & Mello, supra note 8, at 
990; Jack Healy, New Scrutiny on Sweets with Ascent of Marijuana, N.Y. TIMES, 
Oct. 30, 2014, at A13. The same fundamental mistake—marketing marijuana 
products to minors—sank reform efforts in the 1970s. See EMILY DUFTON, GRASS 
ROOTS: THE RISE AND FALL AND RISE OF MARIJUANA IN AMERICA 75 (2017) (“the 
movement’s peak [in the 1970s] also brought with it the movement’s downfall. 
Much of the new paraphernalia for sale deliberately riffed on children’s toys, as 
smokers were offered everything from pot-themed Frisbees and board games to 
Christmas stockings. Even more troubling, children were quickly becoming the 
targets of paraphernalia marketing themselves. By 1978, newspapers were 
reporting that kids had easy access to head shops and were able to purchase 
pipes, papers, and bongs with no questions asked. The paraphernalia market that 
sprang up in the wake of decriminalization developed too quickly for government 
oversight and, with its interest in profits and giving the growing smoking 
population what it desired, it also chose not to regulate itself. In doing so, it set 
itself up for its own demise when a new generation of marijuana activists—
parents angry at the rising rate of adolescent pot use—emerged in the wake of 
the paraphernalia boom. Once they made their power felt, it would be decades 
before decriminalization was spoken of positively in Washington again.”). 
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not occur before the state legalization efforts began: what to 
do about the open-and-obvious public commercial 
distribution of food containing an illegal substance that 
poses unique harms for minors. 
II. THE PROBLEM OF MARIJUANA USE BY MINORS 
Advocates for the liberalization of the marijuana laws 
argue that, because marijuana is no more harmful than 
alcohol, the government should treat the two drugs alike, 
allowing cannabis to be regulated and sold. Treating 
marijuana like alcohol during Prohibition not only deprives 
people of its benefits in the medicinal treatment of conditions 
like chemotherapy-induced nausea, epilepsy-induced 
seizures, and multiple sclerosis spasticity, but also leads to 
considerable social harms.25 A better approach, supporters 
 
 25. The most commonly cited therapeutic uses of cannabinoids are for the 
treatment of chemotherapy-induced nausea and emesis, AIDS-induced anorexia 
and cachexia (HIV/AIDS wasting), and the neuropathic pain and spasticity 
caused by multiple sclerosis. See, e.g., BRITISH MED’L ASS’N, THERAPEUTIC USES OF 
CANNABIS 21–49 (1997); NAT’L ACAD. REP., supra note 5, at 53–54 (listing 
conditions for which marijuana is a treatment for which there are varying 
degrees of scientific support); HUDAK, supra note 15, at 15, 22 (noting that 
cannabidiol, an ingredient of cannabis ingredient, has anticonvulsive and anti-
inflammatory properties); JERROLD S. MEYER & LINDA F. QUENZER, 
PSYCHOPHARMACOLOGY: DRUGS, THE BRAIN, AND BEHAVIOR 410–11 (2d ed. 2018); 
Alan J. Budney et al., Cannabis, in LOWINSON AND RUIZ’S SUBSTANCE ABUSE: A 
COMPREHENSIVE TEXTBOOK 233 (Pedro Ruiz & Eric Strain eds., 5th ed. 2011); see 
also Marcus A. Bachhuber et al., Medical Cannabis Laws and Opioid Analgesic 
Overdose Mortality in the United States, 1999–2010, 174 JAMA INTERNAL MED. 
1668 (2014) (reporting that there were fewer opioid overdoses in states with 
medical marijuana laws); Wayne Hall & Louisa Degenhardt, Adverse Health 
Effects of Non-Medical Cannabis Use, 374 LANCET 1383, 1389 (2009) (“The public 
health burden of cannabis use is probably modest compared with that of alcohol, 
tobacco, and other illicit drugs.”); Gemayel Lee et al., Medical Cannabis for 
Neuropathic Pain, 22 CURRENT PAIN & HEADACHE REP. 8 (2018) (“Nearly 20 years 
of clinical data supports the short-term use of cannabis for the treatment of 
neuropathic pain.”); Philip McGuire et al., Cannabidiol (CBD) as an Adjunctive 
Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial, 175 AM. 
J. PSYCHIATRY 225 (2018); Madeline H. Meier et al., Associations between 
Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal 
Comparison of Persistent Cannabis versus Tobacco Users, 73 JAMA PSYCHIATRY 
731 (2016); Theresa H.M. Moore et al., Cannabis Use and Risk of Psychotic or 
Affective Mental Health Outcomes: A Systematic Review, 370 LANCET 319 (2007); 
2018] MARIJUANA EDIBLES 323 
argue, is to legalize and regulate the growth and distribution 
of marijuana and its products.26 That regulation would 
exclude minors from recreational use.27 
Opponents fundamentally disagree with liberalization’s 
supporters over the relative safety of marijuana. They argue 
that, at bottom, marijuana is a harmful substance. As Dr. 
Nora Volkow, Director of the National Institute on Drug 
 
Penny F. Whiting et al., Cannabinoids for Medical Use: A Systematic Review and 
Meta-Analysis, 313 J. AM. MED’L ASS’N 2456, 2467 (2015); see generally CAULKINS 
ET AL., MARIJUANA LEGALIZATION, supra note 5, at 67–68, 88–89, 131–57 
(collecting arguments and authorities). In that regard, supporters contend that 
smoking marijuana provides benefits not offered by other THC delivery vehicles 
(e.g., pills, inhalants, and suppositories) approved by the U.S. Food and Drug 
Administration (e.g., Dronabinol) or other nations (e.g., Nabiximol), because 
inhalation works more effectively and more quickly, reaching the brain within 
seconds. See, e.g., NAT’L ACAD. REP., supra note 5, at 54; IVERSEN, supra note 12, 
at 41–47; Sunil K. Aggarwal et al., Medicinal Use of Cannabis in the United 
States: Historical Perspectives, Current Trends, and Future Directions, 5 J. 
OPIOID MGMT. 153, 163–64 (2009); see generally Larkin, Marijuana Debate, supra 
note 6 (manuscript at 2–4, nn.9–21) (summarizing arguments and collecting 
authorities). The World Health Organization (WHO) Expert Committee on Drug 
Dependence (ECDD) recently recommended examining the proper classification 
“[p]reparations containing almost exclusively CBD” because they are not likely 
to be addictive and can be used for medical purposes, such as calming spasms 
during epileptic fits. See WORLD HEALTH ORGAN., CANNABIDIOL (COMPOUND OF 
CANNABIS): ONLINE Q&A (Dec. 2017), http://www.who.int/features/qa/
cannabidiol/en/; ESSENTIAL MEDICINES AND HEALTH PRODUCTS, WHO 
RECOMMENDS THE MOST STRINGENT LEVEL OF INTERNATIONAL CONTROL FOR 
SYNTHETIC OPIOID CARFENTANIL (DEC. 2017), http://www.who.int/medicines/
news/2017/WHO-recommends-most-stringent-level-int-control/en/ (“Recent 
evidence from animal and human studies shows that [cannabidiol’s] use could 
have some therapeutic value for seizures due to epilepsy and related conditions. 
Current evidence also shows that cannabidiol is not likely to be abused or create 
dependence as for other cannabinoids (such as [THC], for instance). The ECDD 
therefore concluded that current information does not justify scheduling of 
cannabidiol and postponed a fuller review of cannabidiol preparations to May 
2018, when the committee will undertake a comprehensive review of cannabis 
and cannabis related substances.”); Letter from Dr. Tedros Ahhanom 
Ghebreyesus, Director-General, WHO, to Antonio Guterres, Secretary-General of 
the United Nations (Nov. 27, 2017) (noting that the WHO ECDD recommended 
a later “critical review” of “[p]reparations containing almost exclusively 
cannabidiol (CBD)” (emphasis omitted)); id. Annex 1, at 7. 
 26. See, e.g., CAULKINS ET AL., MARIJUANA LEGALIZATION, supra note 5, at 131–
57. 
 27. See id. at 131. 
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Abuse, once wrote, “[m]arijuana is not a benign drug. It is 
illegal and has significant adverse health effects and 
consequences associated with its use.”28 Opponents maintain 
that marijuana use can be harmful to adults,29  but can cause 
 
 28. Nora D. Volkow, Marijuana and Medicine: The Need for a Science-Based 
Approach, in Sanford & Avoy, supra note 12, at 23, 28; see also NAT’L INST., 
MARIJUANA, supra note 22, at 14 (endnote omitted) (“Marijuana use can lead to 
the development of problem use, known as a marijuana use disorder, which takes 
the form of addiction in severe cases. Recent data suggest that 30 percent of those 
who use marijuana may have some degree of marijuana use disorder.”); NAT’L 
INST., MARIJUANA, supra, at 3 (“[C]ontrary to popular belief, marijuana can be 
addictive, and its use during adolescence may make other forms of problem use 
or addiction more likely.”); WAYNE HALL & ROSALIE LICCARDO PACULA, CANNABIS 
USE AND DEPENDENCE: PUBLIC HEALTH AND PUBLIC POLICY (2003) (“A cannabis 
dependence syndrome occurs in heavy chronic users of cannabis. Regular 
cannabis users develop tolerance to THC, some experience withdrawal symptoms 
on cessation of use, and some report problems controlling their cannabis use. The 
risk of dependence is about one in ten among those who ever use the drug, 
between one in five and one in three among those who use cannabis more than a 
few times, and around one in two among daily users.”); David A. Gorelick et al., 
Diagnostic Criteria for Cannabis Withdrawal Syndrome, 123 DRUG & ALCOHOL 
DEPENDENCE 141 (2012); Deborah S. Hasin et al., Prevalence of Marijuana Use 
Disorders in the United States Between 2001–2002 and 2012–2013, 72 JAMA 
PSYCHIATRY 1235 (2015); Sheryl Ryan & Seth D. Ammerman, Counseling Parents 
and Teens About Marijuana Use in the Era of Legalization of Marijuana, 139 
PEDIATRICS E2 (2017) [hereinafter Ryan & Ammerman, Counseling Parents and 
Teens]. As if to make a bad situation worse, according to a 2015 publication by 
the Centers for Disease Control and Prevention, individuals who are addicted to 
marijuana are three times as likely to become addicted to heroin. See Today’s 
Heroin Epidemic Infographics, CTRS. DISEASE CONTROL & PREVENTION, 
https://www.cdc.gov/vitalsigns/heroin/infographic.html (last updated July 7, 
2015). 
 29. See, e.g., U.S. DEP’T HEALTH & HUM. SERVS., FACING ADDICTION IN 
AMERICA: THE SURGEON GENERAL’S REPORT ON ALCOHOL, DRUGS, AND HEALTH 65 
(Nov. 2016); WORLD HEALTH ORG., THE HEALTH AND SOCIAL EFFECTS OF 
NONMEDICAL CANNABIS USE 15 (2016) [hereinafter WHO REPORT] (“The daily use 
of cannabis over years and decades appears to produce persistent impairments 
in memory and cognition, especially when cannabis use begins in 
adolescence . . . .”); AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL 
OF MENTAL DISORDERS 509–16 (5th ed. 2013) [hereinafter DSM-5] (discussing 
“Cannabis Use Disorder”); HALL & PACULA, supra note 28; MEYER & QUENZER, 
supra note 25, at 416 (“Heavy cannabis use for a long period of time may lead to 
impaired executive functioning for at least 2 to 3 weeks following cessation of 
use. . . . However, some of the data suggest that heavy, long-time users may 
continue to show impairment in decision making, planning, and concept 
formation.”); id. at 420 (ten percent of marijuana users become dependent, while 
fifty percent of daily users do so); id. at 422–25 (discussing potential adverse 
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psychological, neuropsychiatric, and physiological effects from long-term use); id. 
at 424–25 (discussing potential psychosis-causing effect of early-onset, long-term 
use); ROOM ET AL., supra note 2, at 25 (“The risk of dependence is about 9% among 
persons who have ever used cannabis . . . and about one in six for young people 
who initiate in adolescence,” although the risk of dependence is greater for 
nicotine, alcohol, stimulants, cocaine, and heroin); id. at 27 (“There are good 
reasons for believing that cannabis can cause cancers of the lung and 
aerodigestive tract . . . .”); id. at 43–44 (summarizing potential harms); Budney 
et al., in Ruiz & Strain, supra note 25, at 214 (“Clearly cannabis misuse and 
addiction are real and relatively common phenomenon that pose a significant 
public health issue . . . .”); id. at 227–28 (“Whether or not cannabis use can induce 
acute psychosis or contribute to the development of more chronic psychotic 
disorders (e.g., schizophrenia) also remains controversial, although data 
supporting such a causal relationship are emerging. . . . Estimates of attributable 
risk suggest that cannabis may play a role in approximately 1 of 10 cases.”) 
(endnote omitted); Madras, supra note 12, at 16–17, 19–25; Kalant, supra note 
12, at 387–412; Bertha Madras, Introduction, in CELL BIOLOGY OF ADDICTION 1, 8 
(Bertha Madras et al. eds., 2006); Peter Allebeck, Psychopathological 
Manifestations of Cannabis Use, in DRUG ABUSE IN THE DECADE OF THE BRAIN 
159–65 (Gabriel G. Nahas & Thomas F. Burks eds., 1997); Rabi Abouk & Scott 
Adams, Examining the Relationship between Medical Cannabis Laws and 
Cardiovascular Deaths in the US, 53 INT’L J. DRUG POL’Y 1, 5 (2018) (“Our study 
finds evidence suggesting that MCL [viz., medical cannabis legalization] was 
followed by increased cardiac mortality in states passing such laws compared 
with those that did not. This effect was concentrated among older individuals, 
particularly males, and states where there are less restrictions on dispensaries 
and cardholders.”); Louise Arseneault et al., Causal Association Between 
Cannabis and Psychosis: Examination of the Evidence, 184 BRIT. J. PSYCHIATRY 
110, 113 (2004); Amber L. Bahorik et al., Adverse Impact of Marijuana Use on 
Clinical Outcomes Among Psychiatry Patients with Depression and Alcohol Use 
Disorder, 259 PSYCHIATRY RES. 316, 320–21 (2017); Wilson M. Compton et al., 
Marijuana Use and Use Disorder in Adults in the USA, 2002–2014: Analysis of 
Annual Cross-Sectional Surveys, 3 LANCET PSYCHIATRY 954, 961 (2016); Marta Di 
Forti et al., Proportion of Patients in South London with First-Episode Psychosis 
Attributable to Use of High Potency Cannabis: A Case-Control Study, 2 LANCET 
PSYCHIATRY 233, 236 (2015) (“People who used cannabis or skunk every day were 
both roughly three times more likely to have a diagnosis of a psychotic disorder 
than were those who never used cannabis . . . .”); Herman Friedman, 
Neuroimmunology and Marijuana, in DRUG ABUSE IN THE DECADE OF THE BRAIN, 
supra note 29, at 145–51; Wayne Hall, What Has Research over the Past Two 
Decades Revealed about the Adverse Health Effects of Recreational Cannabis 
Use?, 110 ADDICTION 19, 29–30 (2015); Hall & Degenhardt, supra note 25; 
Hannah J. Jones et al., Association of Combined Patterns of Tobacco and 
Cannabis Use in Adolescence with Psychotic Experiences, 75 JAMA PSYCHIATRY 
240 (2018); Peter Manza et al., Subcortical Local Functional Hyperconnectivity 
in Cannabis Dependence, 3 BIOLOGICAL PSYCHIATRY: CNNI 285 (2017); Mark 
Olfson et al., Cannabis Use and Risk of Prescription Opioid Use Disorder in the 
United States, 175 AM. J. PSYCHIATRY 47, 49–50 (2018); Nadia Solowij et al., 
Differential Impairments of Selective Attention due to Frequency and Duration of 
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even greater injury to minors, especially if it leads to heavy 
or long-term use.30 Several respected government and 
 
Cannabis Use, 37 BIOLOGICAL PSYCHIATRY 731, 737 (1995); Marie Stefanie Kejser 
Starzer et al., Rates and Predictors of Conversion to Schizophrenia or Bipolar 
Disorder Following Substance-Induced Psychosis, 175 AM. J. PSYCHIATRY 345 
(2017) (“We found that 32.2% of patients with a substance-induced psychosis 
later converted to either bipolar disorder or schizophrenia. The highest 
conversion rate (47.4%) was found for cannabis-induced psychosis. Young age 
was associated with a higher risk of conversion to schizophrenia; the risk was 
highest for those in the range of 16–25 years. Self-harm after a substance-induced 
psychosis was significantly linked to a higher risk of converting to both 
schizophrenia and bipolar disorder.”); Nora D. Volkow et al., Adverse Health 
Effects of Marijuana Use, 370 NEW ENG. J. MED. 2219, 2220 (2014). An additional 
type of harm can result from attempts to extract THC from marijuana in home 
laboratories. See Monte et al., supra note 5, at 241–42 (“The University of 
Colorado burn center has experienced a substantial increase in the number of 
marijuana-related burns. In the past 2 years, the burn center has had 31 
admissions for marijuana-related burns; some cases involve more than 70% of 
body surface area and 21 required skin grafting. The majority of these were flash 
burns that occurred during THC extraction from marijuana plants using butane 
as a solvent.”). 
 30. See WHO REPORT, supra note 29, at 16 (“Accumulating evidence reveals 
that regular, heavy cannabis use during adolescence is associated with more 
severe and persistent negative outcomes than use during adulthood.”); KOOB ET 
AL., supra note 11, at 269, 279–87 (2014); ROOM ET AL., supra note 2, at 31–39 
(describing studies investigating the risk that adolescent marijuana use could 
adversely affect learning, result in a greater drop-out rate, be a prelude to other 
drug use, or lead to schizophrenia or depression); Madras, supra note 12, at 14–
15; Hall, supra note 29, at 24–26; Volkow, supra note 29, at 2220 (noting that 
negative effects in brain development, educational outcome, cognitive 
impairment, and life satisfaction are “strongly associated with initial marijuana 
use early in adolescence”); see also Manzar Ashtari et al., Diffusion Abnormalities 
in Adolescents and Young Adults with a History of Heavy Cannabis Use, 43 J. 
PSYCHIATRIC RES. 189, 201–02 (2009); Carlos Blanco et al., Cannabis Use and 
Incidence of Psychiatric Disorders: Prospective Evidence from a US National 
Longitudinal Study, 73 JAMA PSYCHIATRY 388 (2016); Matthijs G. Bossong & 
Raymond J.M. Niesink, Adolescent Brain Maturation, the Endogenous 
Cannabinoid System and the Neurobiology of Cannabis-Induced Schizophrenia, 
92 PROGRESS NEUROBIOLOGY 370 (2010); J. S. Brook et al., Early Adolescent 
Marijuana Use: Risks for the Transition to Young Adulthood, 32 PSYCHOL. MED. 
79 (2002); R. Andrew Chambers et al., Developmental Neurocircuitry on 
Motivation in Adolescence: A Critical Period of Addiction Vulnerability, 160 AM. 
J. PSYCHIATRY 1041 (2003); Michael D. De Bellis et al., Neural Mechanisms of 
Risky Decision-Making and Reward Response in Adolescent Onset Cannabis Use 
Disorder, 133 DRUG & ALCOHOL DEPENDENCE 134 (2013); Donald M. Dougherty 
et al., Impulsivity, Attention, Memory, and Decision-Making Among Adolescent 
Marijuana Users, 226 PSYCHOPHARMACOLOGY 307 (2013); David M. Fergusson & 
Joseph M. Bolden, Cannabis Use and Later Life Outcomes, 103 ADDICTION 969, 
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private organizations—the American Medical Association, 
the American Psychiatric Association, the American 
Academy of Pediatrics, the American Cancer Society, the 
 
969 (2008); D. M. Fergusson et al., Cannabis Dependence and Psychotic 
Symptoms in Young People, 33 PSYCHOL. MED. 15, 20 (2003); Charles B. Fleming 
et al., Examination of the Divergence in Trends for Adolescent Marijuana Use and 
Marijuana-Specific Risk Factors in Washington State, 59 J. ADOLESCENT HEALTH 
269, 269–70 (2016); Jodi M. Gilman et al., Cannabis Use Is Quantitatively 
Associated with Nucleus Accumbens and Amygdala Abnormalities in Young 
Adult Recreational Users, 34 J. NEUROSCIENCE 5529, 5537 (2014); Hall, supra 
note 11, at 24–26; Kim Kiser, Rocky Mountain Reality, MINN. MED., Apr. 2014, at 
12, 12 (interview with Jan Kief, M.D.) (“Seventy-four percent of teens in the 
Denver area who are in treatment said they used someone else’s medical 
marijuana on average 50 times.”); Dan I. Lubman et al., Cannabis and Adolescent 
Brain Development, 148 PHARMACOLOGY & THERAPEUTICS 1, 10 (2015); Michael 
Lynskey & Wayne Hall, The Effects of Adolescent Cannabis Use on Educational 
Attainment: A Review, 95 ADDICTION 1621 (2000); Madeline H. Meier, et al., 
Persistent Cannabis Users Show Neuropsychological Decline from Childhood to 
Midlife, 109 PROC. NAT’L ACAD. SCI. E2657 (2012); Bridget Onders et al., 
Marijuana Exposure Among Children Younger than Six Years in the United 
States, 55 CLINICAL PEDIATRICS 428 (2016); Edmund Silins et al., Young Adult 
Sequelae of Adolescent Cannabis Use: An Integrative Analysis, 1 LANCET 
PSYCHIATRY 286 (2014); Nadia Solowij et al., Verbal Learning and Memory in 
Adolescent Cannabis Users, Alcohol Users and Non-Users, 216 
PSYCHOPHARMACOLOGY 131 (2011); Joan E. Zweben & Judith Martin, Physician 
Recommendations for Marijuana: Special Populations and Contraindications, in 
Sanford & Avoy, supra note 12, at 91, 94; Valérie Wolff et al., Cannabis Use, 
Ischemic Stroke, and Multifocal Intracranial Vasoconstriction: A Prospective 
Study in 48 Consecutive Young Patients, 42 STROKE 1778 (2011); see generally 
Volkow, supra note 28, at 2219 (“The regular use of marijuana during adolescence 
is of particular concern, since use by this age group is associated with an 
increased likelihood of deleterious consequences . . . .” (footnote and citation 
omitted); id. at 2220 (noting that “[a]ltered brain development,” “[p]oor 
educational outcome,” “cognitive impairment,” and “[d]iminished life 
satisfaction” are “strongly associated with initial marijuana use early in 
adolescence”). Recently, an eleven-month old infant died from what physicians 
surmised (because no other cause was found) was marijuana-induced myocarditis 
(inflammation of the heart muscle). See Thomas M. Nappe & Christopher O. 
Hoyte, Pediatric Death Due to Myocarditis After Exposure to Cannabis, 1 
CLINICAL PRAC. & CASES EMERGENCY MED. 166 (2017); see also Andrew Blake, 
Marijuana Overdose Killed 11-Month-Old Infant, Doctors Claim, WASH. TIMES 
(Nov. 16, 2017), https://www.washingtontimes.com/news/2017/nov/16/
marijuana-overdose-killed-11-month-old-infant-doct/; Ellie Silverman, The Truth 
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American Academy of Ophthalmology, the National Institute 
for Drug Abuse, and others—have noted those harms and 
agree that minors should not use cannabis.31 
Of particular concern in the case of minors is the 
neurophysiological effect that THC has on the juvenile brain. 
According to one textbook, “[g]rowing evidence suggests that 
marijuana use during adolescence affects normal 
physiological maturation processes in the frontal cortex.”32 
Those adverse effects could be a contributory factor to future 
problems with executive functioning and impulse control, 
including substance use disorders.33 
 
 31. See, e.g., U.S. FOOD & DRUG ADMIN., FDA AND MARIJUANA (Feb. 28, 2017) 
(“The FDA has not approved marijuana as a safe and effective drug for any 
indication.”); NAT’L INST., MARIJUANA, supra note 22, at 17; AM. ACAD. 
OPHTHALMOLOGY, COMPLEMENTARY THERAPY ASSESSMENT: MARIJUANA IN THE 
TREATMENT OF GLAUCOMA 1 (2014); AM. CANCER SOC’Y, MEDICAL USE OF 
MARIJUANA: ACS POSITION 3 (2013); AM. MED. ASS’N HOUSE OF DELEGATES, 
REPORT OF REFERENCE COMMITTEE K 6–7 (2014); AM. PSYCHIATRIC ASS’N, POSITION 
STATEMENT ON MARIJUANA AS MEDICINE (Dec. 2013); HALL & PACULA, supra note 
28, at 214–17 (discussing adverse effects to cells and to immunological, 
reproductive, cardiovascular, respiratory, and gastrointestinal systems, as well 
as the risk of precipitating psychosis in vulnerable individuals); Ryan & 
Ammerman, Counseling Parents and Teens, supra note 28, at e2; Volkow et al., 
supra note 28; cf. AM. EPILEPSY SOC’Y, AES POSITION ON MEDICAL MARIJUANA 
(Mar. 21, 2016) (“The anecdotal reports of positive effects of the marijuana 
derivative cannabidiol (CBD) for some individuals with treatment-resistant 
epilepsy give reason for hope. However, we must remember that anecdotal 
reports alone are not sufficient to support treatment decisions.”). Infrequent or 
“experimental” marijuana use, however, generally is a different matter. There 
might be an exception for use of high-potency THC, low cannabidiol content 
marijuana, colloquially known as “skunk.” Marijuana with a very high THC:CBD 
ratio can give rise to psychotic episodes. See Marta Di Forti et al., supra note 29, 
at 236. A novice using such cannabis might have such an episode from his first 
use. A child, almost certainly. 
 32. KOOB ET AL., supra note 11, at 287. “Executive functioning” means “the 
ability to organize thoughts and activities, prioritize tasks, manage time, and 
make decisions.” Id. at 286. Marijuana use can also harm children in utero. See, 
e.g., WHO REPORT, supra note 29, at 28 (citations omitted) (“[A]ccumulating 
evidence suggests that prenatal cannabis exposure may interfere with normal 
development and maturation of the brain. Children exposed to cannabis in utero 
demonstrate impaired attention, learning and memory, impulsivity and 
behavioural problems and a higher likelihood of using cannabis when they 
mature . . . .”). 
 33. See KOOB ET AL., supra note 11, at 287. 
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Since the 1960s, scientists have discovered that the 
human brain maturation process extends into a person’s 
mid-twenties as the brain creates neurons while pruning and 
reorganizing neural pathways for efficient use by adults.34 
The process of ongoing development is particularly 
important in connection with the prefrontal cortex, the 
region responsible for higher mental functions such as 
reasoning, judgment, and decision-making. Given the labile 
state of the adolescent brain, and depending on the dose and 
frequency of use, a minor’s use of a psychoactive substance 
like THC is likely to have adverse physical and mental effects 
that would not occur in an adult or, even if they did, would 
not be present to the same degree.35 The result hampers 
 
 34. See, e.g., Seth Ammerman et al., The Impact of Marijuana Policies on 
Youth: Clinical, Research, and Legal Update, 135 PEDIATRICS E769, E771 (2015) 
[hereinafter Ammerman et al., Marijuana Policies]; Bossong & Niesink, supra 
note 30, at 372–77; Madras, supra note 12, at 14–15; Ryan & Ammerman, 
Counseling Parents and Teens, supra note 28, at E2. In fact, the prefrontal lobe 
region is the last area of the adolescent brain to undergo the neuromaturational 
development resulting from the extension of neurons into new regions and the 
pruning of unnecessary connections. See, e.g., Ammerman et al., Marijuana 
Policies, supra, at E770; Bossong & Niesink, supra, at 373. 
 35. See Kalant, supra note 12, at 394 (noting “the possibility that during brain 
maturation in adolescence, heavy exposure to cannabis might prevent the growth 
of axons and the establishment of large numbers of synaptic connections that 
normally accompany experience and learning”) (citations omitted); id. (“the 
results of MRI studies of the brains of late teen-aged males who had used 
marijuana heavily throughout adolescence” revealed a “smaller brain size and 
thinner cortex in early heavy users than in age-matched users who did not begin 
until after 17”); Ammerman et al., Marijuana Policies, supra note 34, at E770 
(noting adverse “effects of marijuana use on hippocampal, prefrontal cortex, and 
white matter volume” in minors); Sarah D. Lichenstein et al., Nucleus Accumbens 
Functional Connectivity at Age 20 Is Associated with Trajectory of Adolescent 
Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood, 112 
ADDICTION 1961 (2017); Meier et al., supra note 30 (noting that the “results of 
several studies showing executive functioning or verbal IQ deficits among 
adolescent-onset but not adult-onset chronic cannabis users . . . as well as studies 
showing impairment of learning, memory, and executive functions in samples of 
adolescent cannabis users”) (endnotes omitted); Volkow et al., supra note 28, at 
2220 (“The brain remains in a state of active, experience-guided development 
from the prenatal period through childhood and adolescence until the age of 
approximately 21 years. . . . The negative effect of marijuana use on the 
functional connectivity of the brain is particularly prominent if use starts in 
adolescence or young adulthood, which may help to explain the finding of an 
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development of higher-order mental states necessary for 
mature reasoning and planning.36 
Those adverse effects can manifest themselves in several 
ways. As the American Academy of Pediatrics has noted,37 
numerous published studies have established the harmful 
short- and long-term effects suffered by minors—from 
infants to adolescents—resulting from unwitting THC 
consumption or heavy, long-term marijuana use. Aside from 
intoxication, the range of effects include: decreased 
concentration, attention span, diminished judgment, 
reaction time, tracking ability, and problem-solving skills, 
which hampers driving ability; short-term memory loss; 
respiratory deficits or arrests; and increased risk of mental 
 
association between frequent use of marijuana from adolescence into adulthood 
and significant declines in IQ. The impairments in brain connectivity associated 
with exposure to marijuana in adolescence are consistent with preclinical 
findings that the cannabinoid system plays a prominent role in synapse 
formation during brain development.”) (footnotes omitted). Heavy or long-term 
cannabis use appears to be a critical factor. See Madeleine H. Meier, Associations 
Between Adolescent Cannabis Use and Neuropsychological Decline: A 
Longitudinal Co-Twin Control Study, 113 ADDICTION 257 (2017) (concluding that 
short-term marijuana use does not appear to cause IQ decline or impair executive 
function); Wendy Swift et al., Are Adolescents Who Moderate Their Cannabis Use 
at Lower Risks of Later Regular and Dependent Cannabis Use?, 104 ADDICTION 
806 (2009) (answering the question posed in title as “Yes”). 
 36. See KOOB ET AL., supra note 11, at 285 (“The adolescent period represents 
a critical phase of development, characterized by specific progressive 
neurobiological maturational processes in the prefrontal cortex that includes 
myelination and synaptic pruning. This period of maturation also involves the 
rearrangement of key neurotransmitter systems, such as glutamate, γ-
aminobutyric acid, dopamine, and Endocannabinoid systems in the frontal 
cortex. Changes in these systems are believed to support the emergence of adult 
cognitive processes. Over the course of adolescence and early adulthood, 
individuals show normative growth in planning, preference for delayed rather 
than immediate rewards, resistance to peer pressure, and impulse control. Many 
of the brain regions that are undergoing these developmental changes may be 
particularly affected by alcohol and marijuana use.”). Of course, the science on 
this subject is not on a par with Newton’s First Law of Motion; there are studies 
to the contrary as well. See, e.g., Ileana Pacheco-Colon et al., Is Cannabis Use 
Associated with Various Indices of Motivation Among Adolescents?, 52 SUBST. USE 
& MISUSE 1 (2017). 
 37. See Ammerman et al., Marijuana Policies, supra note 34, at E670; Ryan 
& Ammerman, Counseling Parents and Teens, supra note 28, at E2. 
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health disorders such as psychosis and depression. 
Adolescent marijuana use is also associated with a lower 
probability of faring well in school—including a greater 
likelihood of being suspended or dismissed from school, a 
higher probability of work dissatisfaction and failure—being 
fired and collecting welfare, later marijuana dependence, use 
of other illegal drugs, and suicide attempts.38 Finally, 
someone who begins long-term use during adolescence is 
likely to suffer negative effects on executive functioning that 
do not recover upon reaching the age of majority, even if use 
is later discontinued.39 The number of minors affected 
multiplies the societal implications of those individual 
harms. The associated harms are troubling too. As two 
commentators noted, “the availability of child-friendly 
edibles could increase the probability of initiation to 
marijuana use, reduce the average age of initiation, and 
increase the frequency and intensity of use among users of 
all ages.”40 
 
 38. See, e.g., Budney et al., in Ruiz & Strain, supra note 25, at 227 (“Cross-
sectional and longitudinal studies have reported a clear association between 
chronic cannabis use and impaired psychological functioning. In particular, 
cannabis has been associated with poorer life satisfaction, increased mental 
health treatment and hospitalization, higher rates of depression, anxiety 
disorders, suicide attempts, and conduct disorder.”) (endnote omitted); Brook et 
al., supra note 29, at 87–88; Silins et al., supra note 29, at 286. Other harms, such 
as comas, are also possible but are rare. See, e.g., WHO REPORT, supra note 29, 
at 48–50. 
 39. See, e.g., NAT’L ACAD. OF SCI., ENG’G, & MED., THE HEALTH EFFECTS OF 
CANNABIS AND CANNABINOIDS: THE CURRENT STATE OF EVIDENCE AND 
RECOMMENDATIONS FOR RESEARCH 18 (2017); Madeline H. Meier et al., Persistent 
Cannabis Users Show Neuropsychological Decline from Childhood to Midlife, 109 
PROC. NAT’L ACAD. SCI. E2657 (2012); Henrietta Szutorisz & Yasmin L. Hurd, 
High Times for Cannabis: Epigenetic Imprint and Its Legacy on Brain and 
Behavior, 85 NEUROSCIENCE & BIOBEHAVIORAL REVS. 93, 98–99 (2018) (“The 
relationship between cannabis use and neuropsychiatric vulnerability is clearly 
complex, but the limited data accrued to date in this fast growing field already 
documents that early exposure during one’s lifetime leaves a long-term epigenetic 
memory mark which sets a legacy even onto future generations.”). 
 40. MacCoun & Mello, supra note 8, at 990. Cf. ROOM ET AL., supra note 2, at 
15 (“The health and psychological effects of regular cannabis use are not as well 
understood as those of alcohol and tobacco, but epidemiological research over the 
past decade has provided evidence that it can have adverse effects on some users, 
332 BUFFALO LAW REVIEW [Vol. 66 
States that have liberalized their marijuana laws have 
attempted to avoid those dangers by, inter alia, limiting 
recreational sales to adults.41 Unfortunately, experience has 
taught that such legal restrictions do not prevent children—
to say nothing of adolescents—from finding the drug in their 
parents’ supply or obtaining it elsewhere and mistakenly 
consuming it, or being deliberately tempted to do so.42 
According to Sgt. Jim Gerhardt of the Colorado Drug 
Investigators Association, “[y]ou have little kids that 
accidentally get into this stuff; they don’t know any better.”43 
He also said that others, such as a neighbor, a friend, a 
schoolmate, a babysitter, or another family member, could 
unwittingly give a child candy not realizing what it is. “Those 
 
particularly those who initiate use in adolescence and use more than weekly for 
years during young adulthood.”). That is troublesome because “[c]annabis use in 
the USA typically begins in the mid to late teens, and is most prevalent in the 
early 20s” and because “about 10% of those who ever use cannabis become daily 
users,” with “another 20% to 30% use cannabis weekly . . . .” Id. at 4–5. “Among 
those who begin to use in their early teens, the risk of developing problem use 
may be as high as one in six . . . .” Id. at 5. 
Two other points are worth noting. First, adolescents who drive after using 
marijuana are at greater risk of being in a motor vehicle accident, particularly if, 
as is often the case, they also consume alcohol. See, e.g., KOOB ET AL., supra note 
11, at 283–84; ROOM ET AL., supra note 2, at 15, 17–19; Larkin, Drugged Driving, 
supra note 4, at 473–80 & nn.87–109. Second, juveniles who begin heavy, long-
term marijuana use can become addicted to it. See Peters & Mechoulam, supra 
note 12, in Stanford & Avoy, supra note 12, at 38–39 (describing the neurobiology 
of addiction); Volkow et al., supra note 28, at 2220 (“[E]arly and regular 
marijuana use predicts an increased risk of marijuana addiction, which in turn 
predicts and increased risk of the use of other illicit drugs. As compared with 
persons who begin to use marijuana in adulthood, those who begin to use in 
adolescence are approximately 2 to 4 times as likely to have symptoms of 
cannabis dependence within 2 years after first use.”) (footnotes omitted). 
 41. MacCoun & Mello, supra note 8, at 989. Minors can use marijuana 
medically only with physician approval and parental consent. See, e.g., COLO. 
CONST. art. XVII, § 14(6). 
 42. See Barrus et al., supra note 11, at 4 (“Not unexpectedly, ingestion was 
the most common route of exposure resulting in most of these [pediatric] 
emergency room visits.”). 
 43. Jeff Rossen & Jovanna Billington, Rossen Reports Update: Edible 
Marijuana that Looks Like Candy Is Sending Kids to the ER, TODAY (Sep. 16, 
2017, 7:41 AM), https://www.today.com/parents/edible-marijuana-looks-candy-
sending-kids-er-t94486. 
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accidental issues are on the rise, and it’s a big problem.”44 In 
the words of Dr. Robert Glatter, a New York City emergency 
room physician, “[t]his is extremely dangerous.”45 
 
 44. Id. 
 45. Id.; see, e.g., Kosa et al., supra note 15, at 58 (noting that a 2016 study 
found that “annual Regional Poison Center pediatric marijuana cases increased 
more than fivefold from 2009 to 2015, and edibles were responsible for 52% of the 
exposures.”); MacCoun & Mello, supra note 8, at 990 (“Whether through 
deliberate acquisition or unknowing consumption, these child-friendly edibles 
increase minors’ risk of exposure to and experimentation with marijuana.”); 
Derek Murray et al., When the Grass Isn’t Greener: A Case Series of Young 
Children with Accidental Marijuana Ingestion, 18 CAN. J. EMERG. MED. 480 
(2016); Nathan et al., supra note 5, at 1746 (“[C]annabis prohibition for adults 
does not prevent underage use. For decades, preventive education reduced the 
rates of alcohol and tobacco use by minors, whereas underage marijuana use has 
fluctuated despite its prohibition for adults. Since the 1970s, 80% to 90% of those 
aged 18 years have consistently reported easy access to the drug.”) (footnote 
omitted); Wang et al., Colorado Study 2009–2015, supra note 15; Wang et al., 
Multistate Study 2005–2011, supra note 14, at 686 (noting an increase in the rate 
of pediatric exposure to marijuana from 2005 to 2011 in states that had passed 
marijuana legislation); George Sam Wang et al., Pediatric Marijuana Exposures 
in a Medical Marijuana State, 167 JAMA PEDIATRICS 630 (2013); 3 Warren 
Middle Schoolers Hospitalized After Eating Marijuana-Laced Cookie Crisp, CBS 
DETROIT (Nov. 15, 2017), http://detroit.cbslocal.com/2017/11/15/students-eat-
marijuana-edibles/ (“Warren Police Commissioner Bill Dwyer said officers were 
called to the Michigan Math and Science Academy on Dequindre Road, 
Wednesday morning, after three young girls had eaten Cookie Crisp cereal coated 
in marijuana oil. . . . ‘When our officers arrived, the principal and parents advised 
the officers that three 8th grade female students had been transported to St. John 
Oakland Hospital after complaints of feelings dizzy and light-headed,’ . . . .”); 11 
Teens Ill After Eating Drug-Laced Gummy Bears, ABC NEWS (July 7, 2017), 
http://abc7chicago.com/news/11-teens-ill-after-eating-drug-laced-gummy-
bears/2192901/; Alaska High School Students’ Parents Turn Them in for Selling 
Pot Gummy Bears, ASSOCIATED PRESS (Dec. 8, 2017), http://www.thecannabist.co/
2017/12/08/alaska-high-school-students-marijuana-gummy-bears/94235/; Dan 
Atkinson, THC-Laced Sweets Causing Concern, BOSTON HERALD (Oct. 31, 2017), 
http://www.bostonherald.com/news/local_coverage/2017/10/thc_laced_sweets_ca
using_concern; Peter Burke, 2 Teens Treated after Ingesting Marijuana-Laced 
Gummy Candies at School, ABC NEWS (Mar. 30, 2017), https://www.local10.com/
education/2-teens-ingest-marijuana-laced-gummy-candies-at-school; Bill Bird, 
Teens Charged in Pot-Laced Gummy Bear Incident at Naperville North, CHI. 
TRIBUNE (Feb. 9, 2017), http://www.chicagotribune.com/suburbs/naperville-
sun/crime/ct-nvs-naperville-more-gummy-arrests-st-0212-20170210-story.html; 
Jessica Chen, One Arrested after Marijuana Gummy Bears Sicken Chula Vista 
Students, ABC NEWS (Apr. 27, 2017), https://www.10news.com/news/one-
arrested-after-marijuana-gummy-bears-sickens-chula-vista-students; K.J. Dell 
‘Antonia, When Marijuana Looks Like Candy, Not Drugs, N.Y. TIMES (Feb. 11, 
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2014), https://parenting.blogs.nytimes.com/2014/02/11/when-marijuana-looks-lik
e-candy-not-drugs/; Keith Farner, GCPS Investigating Edible Medical Marijuana 
Incident at Middle School, Jan. 20, 2017, GWINNETT DAILY POST (Jan. 20, 2017), 
http://www.gwinnettdailypost.com/local/gcps-investigating-edible-medical-marij
uana-incident-at-middle-school/article_14237fd4-fca8-577e-9b59-50b52ddaebd
5.html; Carla Field, Students Eat THC-Laced Gummy Bears; 1 Taken to Hospital, 
Another Arrested, WYFF GREENVILLE (Mar. 21, 2017) http://www.wyff4.com/
article/students-eat-thc-laced-gummy-bears-1-taken-to-hospital-another-arreste
d/9163208; Gummy Candy Found at Florida High School Was Laced with THC, 
JUST BELIEVE RECOVERY CTR., https://justbelieverecovery.com/gummy-candy-thc/ 
(last accessed Dec. 9, 2017); Sheena Jones & Madison Park, Sickened Students 
Suspect Marijuana-Laced Gummy Bears, CNN (Dec. 8, 2016), 
http://www.cnn.com/2016/12/07/us/students-sick-gummy-bears/index.html 
(“Several [14, in fact] high school students were taken to a local hospital after 
eating gummy bears some said may have been laced with marijuana.”); Dal Kalsi, 
Police: Hillcrest High Student Hospitalized, Another Arrested After Eating 
Marijuana-Laced Gummy Bears, FOX CAROLINA (Apr. 18, 2017), 
http://www.foxcarolina.com/story/34964042/police-hillcrest-high-student-arreste
d-after-distributing-marijuana-laced-gummy-bears-at-school; Seth Klamann, 
Parents Ask Casper School Officials to Consider Drug Testing, CASPER STAR 
TRIBUNE (Mar. 8, 2017), http://trib.com/news/local/education/parents-ask-casper-
school-officials-to-consider-drug-testing/article_3195b84f-5820-5dae-a1c5-57001
0591694.html (“Natrona County High School students eating marijuana-laced 
gummy bears on a school bus prompted a group of parents to approach school 
board members about implementing a drug testing policy in the district.”); Lance 
Knobel, Two Berkeley High Students Hospitalized after Eating Marijuana 
Edibles, BERKELEYSIDE (Dec. 2, 2016), http://www.berkeleyside.com/2016/
12/02/two-berkeley-high-students-hospitalized-after-eating-marijuana-edibles/ 
(“[Berkeley High School Principal Sam Pasarow] said parents should remind 
students to never accept food from other students without knowing their origin. 
‘Edible products are particularly dangerous as they can include a range of 
substances and unclear dosages and drug potency,’ he wrote.”); Abby Phillip, 
More and More Little Kids are Finding Mom and Dad’s (Legal) Marijuana Stash, 
WASH. POST (June 9, 2015), https://www.washingtonpost.com/news/wonk/
wp/2015/06/09/more-and-more-little-kids-are-finding-mom-and-dads-legal-marij
uana-stash/?noredirect=on&utm_term=.a0d87a0044cf (“In the places where 
marijuana is legal, more and more children are being accidentally exposed to 
their parents’ drugs, a new study found. . . . [B]etween 2006 and 2013, the rate of 
exposure increased by 147.5 percent. . . . Accidental ingestions, which account for 
a whopping 75 percent of cases, are much more likely with the growing 
availability of marijuana edibles. Most of these kids are probably ingesting 
marijuana accidentally—on account of their natural curiosity and the fact that 
the products themselves can taste like treats, researchers said. A majority of the 
children exposed to marijuana were 3 years old or younger, according to the 
study.”); Kristine Phillip, A Fifth Grader Thought She Brought Gummy Bears to 
School. They Were Laced with Marijuana, WASH. POST (Jan. 21, 2018) (on file 
with author) (“A 9-year-old student in New Mexico gave fellow students 
gummies—only to realize later they were not ordinary candies. The candies had 
apparently been laced with [THC] the chemical responsible for how marijuana 
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Proof can be seen in the increase in calls to poison control 
centers. From 2005 through 2011, there was no increase in 
the call rate to poison control centers in states where 
marijuana use was illegal, but there was a thirty percent 
increase in the number of calls in states that had 
decriminalized marijuana use.46 The rate of exposure is also 
increasing. There was no change in the rate between 2000 
and 2006, but the rate increased by 147.5% from 2006 
through 2013.47 The number of reports is also significant: 
1,969 children under six years old were reported for 
marijuana exposure to poison control centers from 2000 
through 2013.48 More than seventy-five percent of the 
children exposed to marijuana were under three years old.49 
One study noted that “[s]tates that decriminalized medical 
marijuana have shown an increase in emergency department 
(ED) visits and regional poison center (RPC) cases for 
unintentional pediatric marijuana exposures.”50 Colorado, in 
particular, saw a thirty-four percent increase in marijuana 
exposure cases between 2009 and 2015—an amount greater 
 
affects the brain and were being used by the student’s parents as medical 
marijuana.”); Shira Schoenberg, “From Gummy Bears to Open Doors, Inspections 
Identify Problems at Massachusetts Medical Marijuana Dispensaries,” 
MASSLIVE.COM (Jan. 19, 2018), http://www.masslive.com/politics/index.ssf/
2018/01/from_gummy_bears_to_open_doors.html); Rick Wilking, Reuters, Bad 
Munchies: Boy Sent to Hospital after Eating Pot-Laced Gummy Bears on School 
Bus, RT QUESTION MORE (Jan. 13, 2017) https://www.rt.com/usa/373363-
marijuana-gummy-bears-schoolbus/; Lyndsay Winkley, Eighth-Grader Sold Pot-
Laced Gummy Bears to Fellow Students, Authorities Say, L.A. TIMES (Apr. 27, 
2017), http://www.latimes.com/local/lanow/la-me-ln-marijuana-gummy-bears-
20170427-story.html. Even adults can accidentally consume THC-infused food. 
See Barrus et al., supra note 11, at 7 (“Reports of inadvertent ingestion of 
cannabis edibles by adults are widespread. For example, a group of preschool 
teachers in California experienced nausea, dizziness, headache, and other 
symptoms after consuming brownies containing cannabis. One of the teachers 
had purchased the brownies from a sidewalk vendor and placed them in the 
breakroom . . . .”). 
 46. Wang et al., Multistate Study 2005–2011, supra note 14, at 686. 
 47. Onders, supra note 30, at 430. 
 48. Id. 
 49. Id. at 430, 432. 
 50. Wang et al., Colorado Study 2009–2015, supra note 15, at 2. 
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than what occurred in any other state.51 The vast majority of 
exposures were edibles; they accounted for seventy-five 
percent of the exposures.52 That result is particularly likely 
when edibles are shaped and colored to mimic candies 
already familiar to children or infants who are not yet 
intellectually capable of understanding the risks of 
consuming edibles or parental warnings about the harms of 
marijuana use.53 
Of course, children are not the only minors who can 
consume marijuana. Marijuana, including cannabis obtained 
for medical purposes, has been diverted to adolescents, who 
may use edibles to disguise their marijuana use.54 Smoking 
marijuana leaves a signature aroma; ingesting marijuana 
does not. The result is that adolescents may use edibles, 
 
 51. See id. at 4; see also John Ingold, Children’s Hospital Sees Surge in Kids 
Accidentally Eating Marijuana, DENVER POST (Oct. 2, 2016, 4:01 PM), 
http://www.denverpost.com/2014/05/21/childrens-hospital-sees-surge-in-kids-
accidentally-eating-marijuana/ (“The number of children coming into Colorado’s 
largest pediatric emergency department after accidentally eating marijuana is 
on pace to more than double last year’s total. . . . Most of the children admitted 
are between 3 and 7 years old . . . .”). 
 52. See Monte et al., supra note 5, at 242 (“The most concerning health effects 
have been among children. The number of children evaluated in the ED for 
unintentional marijuana ingestion at the Children’s Hospital of Colorado 
increased from 0 in the 5 years preceding liberalization to 14 in the 2 years after 
medical liberalization. This number has increased further since legalization; as 
of September 2014, 14 children had been admitted to the hospital this year, and 
7 of these were admitted to the intensive care unit. The vast majority of intensive 
care admissions were related to ingestion of edible THC products.”); Onders, 
supra note 30, at 430, 432; Wang et al., Multistate Study 2005–2011, supra note 
14, at 684. 
 53. Wang et al., Multistate Study 2005–2011, supra note 14, at 688 (“These 
edible products are often indistinguishable from non-marijuana-containing food 
products, are highly attractive and palatable to children, and can contain very 
high amounts of [THC.]”) (footnote omitted). 
 54. Wang et al., Multistate Study 2005–2011, supra note 14, at 684. Kris 
Kirschner, “Weed Candy” Just One Way Teenagers Hide Marijuana Use, WTHR 
(Apr. 14, 2016, 10:30 PM), https://www.wthr.com/article/weed-candy-just-one-
way-teenagers-hide-marijuana-use (“Across the country, police agencies are 
reporting evidence of a new way to disguise illegal drugs, by wrapping them in 
familiar and innocent looking covers. ‘Weed candy’ is marijuana cooked into hard 
candy—and it’s beginning to make its way into Indiana.”). 
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particularly ones disguised as anodyne candies, to start 
down a path that could lead to the harms resulting from 
prolonged use. 
There are additional risks associated with use of 
marijuana by teenagers. They may be aware that they are 
consuming marijuana, but unaware of the considerable delay 
between ingestion and the psychoactive effect that THC 
produces or of the amount of THC that they can consume in 
a single edible. The result is that they may overconsume the 
amount of marijuana necessary to produce the hoped-for 
euphoria and, instead, have an adverse reaction.55 
Keep in mind that the marijuana grown and sold today 
is not your granddaddy’s ganja. Current products have a 
greater THC content than what was used from the 1960s 
through the 1980s, perhaps due to the effect of competition.56 
 
 55. Cf. BRUCE BARCOTT, WEED THE PEOPLE: THE FUTURE OF LEGAL MARIJUANA 
IN AMERICA 272 (2015) (“It [viz., overconsumption] was a problem because 
industry and state officials miscalculated their dosing rules. A single package of 
recreational edibles in Colorado could contain no more than 100 milligrams of 
THC. That meant one cookie in its own package might max out at 100 milligrams. 
But the state considered a ‘serving size’ to be 10 milligrams. So a single cookie 
might constitute 10 servings. Who looks at a single cookie and thinks, Ten 
servings? Nobody, that’s who.”) (emphasis in original). 
 56. See, e.g., Budney et al., in Ruiz & Strain, supra note 25, at 216 (the 
potency of marijuana increased by sixty percent over 2000–2010); ROOM ET AL., 
supra note 2, at 6 (noting that some varieties of marijuana (Sinsemilla, also 
known as skunk and Netherweed) may have THC content as high as 20 percent, 
that hashish (dried cannabis resin and crushed plants) has a THC content in the 
range of 2–20 percent, and that hash oil (an oil-based extract of hashish) has a 
THC content of 15–50 percent); id. at 39–40; Wayne Hall & Louisa Degenhardt, 
High Potency Cannabis: A Risk Factor for Dependence, Poor Psychosocial 
Outcomes, and Psychosis, 350 BR. MED. J. 1205 (2015); Eric L. Sevigny et al., The 
Effects of Medical Marijuana Laws on Potency, 25 INT’L J. DRUG POL’Y 308, 309 
(2014) (“Although direct empirical evidence is limited, insider and journalistic 
accounts suggest that [medical marijuana laws]—and the medical marijuana 
industry built up around them—have greatly enhanced the development and 
diffusion of high-potency cannabis cultivars and sophisticated techniques of 
production.”); Volkow et al., supra note 29, at 2222 (“The THC content, or potency, 
of marijuana, as detected in confiscated samples, has been steadily increasing 
from about 3% in the 1980s to 12% in 2012. . . . This increase in THC content 
raises concerns that the consequences of marijuana use may be worse now than 
in the past and may account for the significant increases in emergency 
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One study estimates that the potency nearly tripled between 
1990 and 2010 from 3.4% to 9.6%,57 although other studies 
put the number even higher, up to 20%.58 Cannabis oil 
extracts can be as high as 80%.59 The THC content of edibles 
can be especially high.60 In fact, the marijuana industry has 
developed a synthetic crystalline form of THC that is 99.9% 
pure.61 The increase in potency over time persuaded NIDA 
Director Dr. Volkow to question “the current relevance of the 
findings in older studies on the effects of marijuana use, 
especially studies that assessed long-term outcomes.”62 
 
department visits by persons reporting marijuana use . . . and the increases in 
fatal motor-vehicle accidents.”) (footnotes omitted). It is also important to note 
that the relatively low ratio of THC to cannabidiol (CBD) in the native plant may 
have protected earlier generations of users from severe adverse effects. Research 
shows that THC administered alone can have a dramatic adverse effect on critical 
brain biology. The theory is that CBD attenuates the effects of THC in brain 
tissue. See ROOM ET AL., supra note 2, at 15; Di Forti et al., supra note 29, at 236; 
M.A. El Sohly et al., Changes in Cannabis Potency Over the Last Two Decades 
(1995–2014): Analysis of Current Data in the United States, 79 BIOLOGICAL 
PSYCHIATRY 613, 617 (2016). Even if adults can titrate the amount of high-content 
THC they consume, see ROOM ET AL., supra note 2, at 40, children cannot. 
 57. Sevigny et al., supra note 56, at 308, 315 (noting that marijuana potency 
“significantly increases by about one percentage point over time” in states with 
medical marijuana laws). 
 58. See DSM-5, supra note 28, at 511 (marijuana potency ranges from 1–15 
percent, hashish from 10–20 percent; “During the past two decades, a steady 
increase in the potency of seized cannabis has been observed.”); HUDAK, supra 
note 15, at 17–18; IVERSEN, supra note 12, at 10 (estimating potency at 10–20 
percent); Kleber & DuPont, supra note 14, at 565 (estimating up to 20 percent). 
 59. See Beau Kilmer & Rosalie Liccardo Pacula, Understanding and Learning 
from the Diversification of Cannabis Supply Laws, 112 ADDICTION 1128, 1131 
(2016). 
 60. Onders et al., supra note 30, at 432. 
 61. See Anna Wilcox, THC-A Crystalline: The World’s Strongest Hash with 
99.99% THC, HERB (Mar. 29, 2017), https://herb.co/2017/03/29/thc-a-crystalline/. 
A 99% standard is used in Dronabinol, marketed as Marinol, an FDA-approved 
pill-form drug with an isolated THC cannabinoid that is approved for 
chemotherapy-induced nausea. See Dronabinol: Pharmacology and Biochemistry, 
NAT’L CTR. BIOTECHNOLOGY INFO., https://pubchem.ncbi.nlm.nih.gov/compound/
Dronabinol#section=Pharmacology-and-Biochemistry (last visited Mar. 21, 
2018). 
 62. Volkow et al., supra note 28, at 2222. Another consideration is the 
inconsistency in the THC concentration within some products, which can lead 
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Those problems are not isolated or transient ones. On the 
contrary, at least 60% of new drug initiates are younger than 
eighteen years old, the age of onset is declining, daily use of 
marijuana by juveniles is at its highest level in thirty years, 
marijuana use exceeds nicotine use, and 44.5% of twelfth-
graders report having used cannabis, with 6% reporting 
daily use during the preceding thirty days.63 Juvenile 
consumption of THC is a serious public health and policy 
issue. 
III. THE NEED FOR THE FDA TO PROTECT MINORS FROM 
MARIJUANA EDIBLES 
A. State Regulatory Efforts 
States authorizing recreational marijuana use, such as 
Colorado, have sought to prevent those problems from 
occurring by regulating the manufacture, packaging, and 
distribution of edible marijuana.64 For example, four states 
currently have operational recreational marijuana 
programs. Each one forbids the manufacture and packaging 
of products that could appeal to children and requires that 
edibles be sold in child-resistant packaging.65 The level of 
 
some users to overconsume a suggested service portion. See, e.g., Kosa et al., 
supra note 15, at 58. 
 63. See BABOR ET AL., supra, note 8, at 105 (“[A]dolescence is the period of life 
in which drug use is most likely to begin.”); Budney et al., in Ruiz & Strain, supra 
note 25, at 216 (rates of use and incidence of cannabis use disorder increased 
during 1995–2010; marijuana use also initiating at a younger age); Lichenstein 
et al., supra note 35, at 1961; Madras, supra note 12, at 12–13. 
 64. See Barrus et al., supra note 11, at 9–10; Jacob T. Borodovsky & Alan J. 
Budney, Legal Cannabis Laws, Home Cultivation, and Use of Edible Cannabis 
Products: A Growing Relationship, 50 INT’L J. DRUG POL’Y 102, 103 (2017); 
Camille Gourdet et al., How Four U.S. States Are Regulating Recreational 
Marijuana Edibles, 43 INT’L J. DRUG POL’Y 83, 84–89 (2017); Kosa et al., supra 
note 15, at 58–64. In 2016, California, Maine, Massachusetts, and Nevada also 
legalized recreational marijuana use, but, other than California, those programs 
have not yet become operational as of the date of this Article. See Gourdet et al., 
supra, at 83. 
 65. See, e.g., COLO. CODE REGS. § 212-1-1001.5(C) (2017) (prohibiting medical 
marijuana businesses from packaging items “in a manner that specifically 
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targets individuals under the age of 21, including but not limited to, cartoon 
characters or similar images.”); id. § 212-1-1001.5(H) (forbidding the use of the 
word “candy” or “candies” on medical marijuana products); id. §§ 212-1-1004.5(A), 
212-1-1006(A), 212-1-1007(A) (requiring medical marijuana centers to package 
their products in child-resistant containers); id. §§ 212-2-1001 to 212-2-1007.5 
(requiring the same packaging and labeling requirements for retail or 
recreational marijuana); WASH. ADMIN. CODE § 314-55-105(7) (2017) (“Marijuana-
infused products and marijuana concentrates meant to be eaten, swallowed, or 
inhaled, must be packaged in child resistant packaging in accordance with Title 
16 C.F.R. 1700 of the Poison Prevention Packaging Act or use standards specified 
in this subsection. Marijuana-infused product in solid or liquid form may be 
packaged in plastic four mil or greater in thickness and be heat sealed with no 
easy-open tab, dimple, corner, or flap as to make it difficult for a child to open 
and as a tamperproof measure. Marijuana-infused product in liquid form may 
also be sealed using a metal crown cork style bottle cap. Marijuana-infused solid 
edible products. If there is more than one serving in the package, each serving 
must be packaged individually in childproof packaging (see WAC 314-55-105(7)) 
and placed in the outer package. Marijuana-infused liquid edible products. If 
there is more than one serving in the package, a measuring device must be 
included in the package with the product. Hash marks on the bottle do not qualify 
as a measuring device. A measuring cap or dropper must be included in the 
package with the marijuana-infused liquid edible product.”); id. § 314-55-105(11) 
(“All marijuana and marijuana products when sold at retail must include 
accompanying material that is attached to the package or is given separately to 
the consumer containing the following warnings: (a) ‘Warning: This product has 
intoxicating effects and may be habit forming. Smoking is hazardous to your 
health’; (b) ‘There may be health risks associated with consumption of this 
product’; (c) ‘Should not be used by women that are pregnant or breast feeding’; 
(d) ‘For use only by adults twenty-one and older. Keep out of reach of children’; 
(e) ‘Marijuana can impair concentration, coordination, and judgment. Do not 
operate a vehicle or machinery under the influence of this drug’; (f) Statement 
that discloses all pesticides applied to the marijuana plants and growing medium 
during production and processing.”); id. § 314-55-105(13) (“In addition to 
requirements in subsection (10) of this section, labels affixed to the container or 
package containing usable marijuana, or packaged marijuana mix sold at retail 
must include: (a) Concentration of THC (total THC and activated THC-A) and 
CBD (total CBD and activated CBD-A); (b) Date of harvest.”); id. § 314-55-105(14) 
(“In addition to requirements in subsection (10) of this section, labels affixed to 
the container or package containing marijuana-infused products meant to be 
eaten or swallowed sold at retail must include: (a) Date manufactured; (b) Best 
by date; (c) Serving size and the number of servings contained within the unit; 
(d) Total milligrams of active THC, or Delta 9 and total milligrams of active CBD; 
(e) List of all ingredients and major food allergens as defined in the Food Allergen 
Labeling and Consumer Protection Act of 2004; (f) ‘Caution: When eaten or 
swallowed, the intoxicating effects of this drug may be delayed by two or more 
hours.’”); id. § 314-55-106(1) (“Marijuana-infused products meant to be eaten or 
swallowed sold at retail must be labeled on the principal display panel or front of 
the product package with the ‘not for kids’ warning symbol created and made 
available in digital form to licensees without cost by the Washington poison 
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success those states have had in keeping marijuana out of 
the hands of minors, according to one study, “remains an 
open, and somewhat controversial, question.”66 
Additional steps could be taken to prevent access by 
minors.67 Colorado recently took one such step by forbidding 
the sale of any edible product in a form that resembles an 
animate creature.68 Of course, there are numerous other 
shapes that children easily recognize, such as a train, a car, 
a flower, or a classic cuboidal shaped candy bar. The new 
Colorado regulation, therefore, is an incomplete remedy.69 A 
 
center (WPC). The warning symbol may be found on the WPC’s web site. (a) The 
warning symbol must be of a size so as to be legible, readily visible by the 
consumer, and effective to alert consumers and children that the product is not 
for kids, but must not be smaller than three-quarters of an inch in height by one-
half of an inch in width; and (b) The warning symbol must not be altered or 
cropped in any way other than to adjust the sizing for placement on the principal 
display panel or front of the product package, except that a licensee must use a 
black border around the edges of the white background of the warning symbol 
image when the label or packaging is also white to ensure visibility of the warning 
symbol.”); Barrus et al., supra note 11, at 10; Gourdet et al., supra note 64, at 87–
88. 
 66. Gourdet et al., supra note 64, at 87; Ben Tsutaoka et al., Edible Marijuana 
Labeling and Packaging, 57 CLINICAL PEDIATRICS 227, 227–230 (2018) 
(“Compliance of edible marijuana products to California label and packaging 
requirements, set forth in AB-266, was poor. Ninety percent of the products were 
labeled and in a tamper evident package; however, only one was in child-resistant 
packaging. Colorado medical and retail marijuana statutes have provisions for 
child-resistant packaging that conform to federal consumer product safety 
regulations, that products are in opaque packaging so the product cannot be seen 
and that the package is resealable if not single use; still pediatric exposures to 
marijuana increased 5-fold from 2009 to 2015.”) (footnote omitted). 
 67. See MacCoun & Mello, supra note 8, at 990–91 (offering suggestions). 
 68. See COLO. CODE REGS. § 212-2-402(P) (forbidding edibles shaped as, or 
containing characteristics of, humans, animals, or fruit); COLO. REV. STAT. § 12-
43.3-202(1)(b)(I) (2017) (authorizing the state marijuana licensing authority to 
promulgate rules “as necessary for the proper regulation and control of the 
cultivation, manufacture, distribution, and sale of medical marijuana and for the 
enforcement of this article”). 
 69. See Kosa et al., supra note 15, at 58–59; Colorado Marijuana Bill: 
Banning Weed-Infused Gummy Bears, WEEDLEX (July 4, 2016), 
http://weedlex.com/colorado-marijuana-bill-banning-weed-infused-gummy-bears 
(“While sweet edibles in the shape of bears and fish will be illegal to produce, 
cannabis stars, leaves, and many other shapes that should have also fallen within 
the purview of the law are not banned. This conveys that the House Bill 1436 is 
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state could rely on state tort law to supplement regulations. 
One theory would be that an edible resembling a traditional 
form of candy would qualify as an “attractive nuisance,” 
which would enable minors to recover damages from the 
manufacturer and seller of the edible.70 Yet, insofar as the 
blame lies with the parents for failing to prevent a minor 
from accessing their “stash,” allowing, let alone encouraging, 
minors to recover damages from their parents is hardly an 
attractive way to encourage the latter to be careful. 
B. Potential Federal Regulatory Efforts 
The interesting questions are whether the federal 
government can and should intervene to supplement the 
states’ efforts to protect minors. To date, most of the debate 
has focused on the issue of whether the Department of 
Justice should prosecute marijuana dispensaries for 
violating the federal drug laws. Those statutes do not contain 
a medical or personal use exception,71 and, under the 
Supremacy Clause, federal law trumps state law whenever 
the two conflict.72 The result is that state marijuana 
liberalization initiatives do not shield anyone from federal 
 
a completely political action.”). 
 70. See MacCoun & Mello, supra note 8, at 989; see generally RESTATEMENT 
(SECOND) OF TORTS § 339 (AM. LAW INST. 1965); PROSSER & KEETON ON TORTS § 59, 
399-402 (W. Page Keeton et al. eds., 5th ed. 1984). 
 71. See, e.g., Gonzales v. Raich, 545 U.S. 1 (2005) (summarized supra note 7); 
United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 483, 494–95 (2001). 
 72. See U.S. CONST. art. VI, cl. 2 (“This Constitution, and the Laws of the 
United States which shall be made in pursuance thereof; and all treaties made, 
or which shall be made, under the authority of the United States, shall be the 
supreme law of the land; and the judges in every state shall be bound thereby, 
anything in the constitution or laws of any state to the contrary 
notwithstanding.”). The conflict occurs not because the states are obligated to 
prohibit marijuana use. They are not required to adopt any particular criminal 
law; what they must do it notify the public what they do make a crime. See Paul 
J. Larkin, Jr., The Lost Due Process Doctrines, 66 CATH. U. L. REV. 293, 307–08 
(2016). The conflict arises because the state legalization provisions allow an 
activity prohibited by federal law. 
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criminal liability.73 
The Justice Department, however, has not aggressively 
prosecuted individuals or businesses in states with 
liberalized marijuana laws. In part, that approach reflects a 
policy judgment regarding the proper allocation of law 
enforcement resources—a decision that, as explained below, 
Attorney General Jeff Sessions has revisited once and could 
revisit again.74 In part, the Justice Department’s policy 
reflects a limitation imposed by a series of congressional 
appropriations riders that prohibit the department from 
using federal funds to bring to a halt state medical marijuana 
programs.75 The Fiscal Year 2018 appropriations bill carried 
 
 73. See, e.g., United States v. Rosenthal, 454 F.3d 943, 948 (9th Cir. 2006) 
(ruling that the City of Oakland cannot “deputize” someone to distribute 
marijuana under state law and render him immune from prosecution under 
federal law); United States v. Stacy, 734 F. Supp. 2d 1074, 1080 (S.D. Cal. 2010) 
(holding that state medical marijuana laws do not grant a person immunity from 
prosecution under federal law); People v. Crouse, 388 P.3d 39 (Colo. 2017) (ruling 
that the federal Controlled Substances Act preempts state constitutional 
provisions requiring the return to an acquitted defendant of any marijuana seized 
from him). 
 74. During the Clinton and Bush Administrations, the Justice Department 
threatened physicians who prescribed marijuana with the loss of their federal 
license to prescribe controlled substances and said that it aggressively prosecutes 
marijuana distribution businesses. The Justice Department did not prosecute 
individual patients, but it did pursue large-scale companies. During the Obama 
Administration, the Justice Department publicly stated that it would not strictly 
enforce federal law against patients and caregivers but would prosecute parties 
and businesses that operated a marijuana dispensary as a sham for drug 
trafficking or allied crimes, such as money laundering. See Larkin, Drugged 
Driving, supra note 4, at 469–70, 470 n.75. In January 2018, Attorney General 
Sessions repealed the Obama Administration’s Justice Department policies and 
instructed the U.S. Attorneys to make changing decisions based on their own 
assessment of the harms from marijuana trafficking in their respective districts. 
See infra notes 97–99 and accompanying text. 
 75. See Consolidated and Further Continuing Appropriations Act of 2015, 
Pub. L. No. 113-235, § 538, 128 Stat. 2130, 2217 (2014) (“None of the funds made 
available in this Act to the Department of Justice may be used, with respect to 
the States of Alabama, Alaska, Arizona, California, Colorado, Connecticut, 
Delaware, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kentucky, Maine, 
Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, 
Montana, Nevada, New Hampshire, New Jersey, New Mexico, Oregon, Rhode 
Island, South Carolina, Tennessee, Utah, Vermont, Washington, and Wisconsin, 
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that provision forward, but it does not apply to recreational 
marijuana programs or to other federal agencies. 
There is an additional issue, however: can and should the 
FDA address the distribution of edible cannabis on the 
ground that THC-infused edibles are an “adulterated” food 
and therefore cannot be distributed through interstate 
commerce? The federal government ordinarily relies on the 
Controlled Substances Act to address drug trafficking 
because of the severity of its penalties, which, in some cases, 
can result in life imprisonment.76 But that statute is not the 
 
to prevent such States from implementing their own State laws that authorize 
the use, distribution, possession, or cultivation of medical marijuana.”); Larkin, 
Drugged Driving, supra note 4, at 464. Congress has carried forward that 
provision in subsequent appropriations acts. See Continuing Appropriations Act, 
2016, Pub. L. No. 114-53, § 104, 129 Stat. 502, 506 (2015); Further Continuing 
Appropriations Act, 2016, Pub. L. No. 114-96, 129 Stat. 2193 (2015); Consolidated 
Appropriations Act, 2016, Pub. L. No. 114-113, § 542, 129 Stat. 2242, 2332–33 
(2015); Continuing Appropriations Act, 2017, Div. C of the Continuing 
Appropriations and Military Construction, Veterans Affairs, and Related 
Agencies Appropriations and Zika Response and Preparedness Act, Pub. L. No. 
114-223, 130 Stat. 857, 908-20 (2016); Further Continuing and Security 
Assistance Appropriations Act, 2017, Pub. L. No. 114-254, § 101, 130 Stat. 1005, 
1006 (2016); H.R.J. Res. No. 99, Pub. L. No. 115-30, 131 Stat. 134 (2017); 
Consolidated Appropriations Act, 2017, Pub. L. No. 115-31, 131 Stat. 135 (2017); 
Continuing Appropriations Act, 2018 and Supplemental Appropriations for 
Disaster Relief Requirements Act 2017, Div. D, Pub. L. No. 115-56, §§ 103–04, 
131 Stat. 1129, 1139–47 (2018); H.R.J. Res. No. 123, Further Continuing 
Appropriations Act, 2018, Div. A, Pub. L. No. 115-90, § 101, 131 Stat. 1280 (2017); 
H.R. Res. 1370, 115th Cong. (2017) (enacted); Consolidated Appropriations Act, 
2018, Pub L. No. 115-141, § 538 (Mar. 23, 2018). The appropriations rider was 
originally named the Rohrabacher-Farr Amendment after the two 
congressmen—Dana Rohrabacher and Sam Farr—who originally introduced it. 
Now, it is known as the Rohrabacher-Blumenauer-Leahy Amendment. See Dana 
Rohrabacher, My Fellow Conservatives Should Protect Medical Marijuana from 
the Government, WASH. POST (Sept. 5, 2017), https://www.washingtonpost.com/
opinions/my-fellow-conservatives-should-protect-medical-marijuana-from-the-go
vernment/2017/09/05/73b60b0a-91aa-11e7-8754-d478688d23b4_story.html?utm
_term=.d31ac2ce3daa; Press Release, Congressman Dana Rohrabacher, 
Rohrabacher Applauds Senate Panel for Adopting ‘Rohrabacher-Farr 
Amendment’ (July 28, 2017), https://rohrabacher.house.gov/media-center/press-
releases/rohrabacher-applauds-senate-panel-for-adopting-rohrabacher-farr. For 
convenience, I will refer to the amendment as the Rohrabacher Amendment. 
 76. See Paul J. Larkin, Jr., Crack Cocaine, Congressional Inaction, and Equal 
Protection, 37 HARV. J. L. & PUB. POL’Y 241, 241–42 (2014) (discussing the penalty 
structure of the Controlled Substances Act). 
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only tool available to the government. The Federal Food, 
Drug, and Cosmetic Act (FDCA) bans the introduction of 
“adulterated” food into interstate commerce in order to 
ensure the purity of the nation’s food supply.77 The question, 
therefore, is whether the FDCA offers the government an 
additional option it can use against the potential harms 
posed by marijuana edibles. 
It appears that the FDCA can be used in that manner. 
The FDCA authorizes criminal prosecution, civil remedies, 
and injunctive relief for a violation of its terms, including the 
seizure of any adulterated foods.78 Under the FDCA, a “food” 
 
 77. 21 U.S.C. § 331(a)–(c) (2012) (“The following acts and the causing thereof 
are prohibited: (a) The introduction or delivery for introduction into interstate 
commerce of any food, drug, device, tobacco product, or cosmetic that is 
adulterated or misbranded. (b) The adulteration or misbranding of any food, 
drug, device, tobacco product, or cosmetic in interstate commerce. (c) The receipt 
in interstate commerce of any food, drug, device, tobacco product, or cosmetic that 
is adulterated or misbranded, and the delivery or proffered delivery thereof for 
pay or otherwise.”). Misbranding of edibles can occur in (at least) two ways: They 
can contain an inaccurate statement of their treatment value for different 
medical conditions. See infra notes 128–37 and accompanying text. Or they can 
mistakenly advertise the amount of THC in a product. See Vandrey et al., supra 
note 18, at 2491 (“Edible cannabis products from 3 major metropolitan areas, 
though unregulated, failed to meet basic label accuracy standards for 
pharmaceuticals. Greater than 50% of products evaluated had significantly less 
cannabinoid content than labeled, with some products containing negligible 
amounts of THC. Such products may not produce the desired medical benefit. 
Other products contained significantly more THC than labeled, placing patients 
at risk of experiencing adverse effects. Because medical cannabis is recommended 
for specific health conditions, regulation and quality assurance are needed.”) 
(footnotes omitted). 
 78. 21 U.S.C. § 332 (2012) (authorizing injunctive relief); id. § 333 
(authorizing criminal and civil penalties); id. § 334(a)(1) (authorizing judicial 
seizure); id. § 334(g)–(h) (authorizing administrative detention of adulterated 
and misbranded food and tobacco products); id. § 335b (authorizing civil 
penalties); see generally 21 C.F.R. § 1.378 (2017) (authorizing administrative 
detention of adulterated foods). The FDCA also authorizes the Commissioner of 
Food, Drugs, and Cosmetics, as the designee of the Secretary of Health and 
Human Services, 21 U.S.C. § 371(a); 21 C.F.R. § 5.10 (2017), to promulgate food 
quality standards. 21 U.S.C. § 341 (“Whenever in the judgment of the Secretary 
such action will promote honesty and fair dealing in the interest of consumers, 
he shall promulgate regulations fixing and establishing for any food, under its 
common or usual name so far as practicable, a reasonable definition and standard 
of identity, a reasonable standard of quality, or reasonable standards of fill of 
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is defined to include “articles used for food or drink for man” 
and “articles used for components of any such article.”79 A 
food is adulterated if it contains any added “poisonous or 
deleterious substance which may render it injurious to 
health”;80 marijuana edibles qualify. Aside from pesticides, 
fungi, and other toxins,81 edibles contain THC, a potentially 
 
container. . . . In prescribing a definition and standard of identity for any food or 
class of food in which optional ingredients are permitted, the Secretary shall, for 
the purpose of promoting honesty and fair dealing in the interest of consumers, 
designate the optional ingredients which shall be named on the label.”). 
 79. 21 U.S.C. § 321(f) (2012). 
 80. Id. § 342(a)(1) (“A food shall be deemed to be adulterated . . . [i]f it bears 
or contains any poisonous or deleterious substance which may render it injurious 
to health . . . .”); id. § 346 (“Any poisonous or deleterious substance added to any 
food, except where such substance is required in the production thereof or cannot 
be avoided by good manufacturing practice shall be deemed to be unsafe for 
purposes of the application of clause (2)(A) of section 342(a) of this title . . . .”); cf. 
COLO. CODE REGS. § 212-2.103 (2017) (“‘Additive’ means any substance added to 
Retail Marijuana Product that is not a common baking or cooking item.”). 
 81. The presence of harmful substances in marijuana products aggravates the 
problem of edibles. Agricultural marijuana is not a standardized product. It can 
vary by region, manner of cultivation, and potential contaminants. See, e.g., 
CAULKINS ET AL., MARIJUANA LEGALIZATION, supra note 5, at 34 (“One reason for 
the lack of consensus is that marijuana is not a standardized good . . . .”); id. at 
68 (“So asking about, or trying to study, the benefits (or harms) of marijuana 
generically is a little bit like asking what wine tastes like, as if merlot and 
champagne were interchangeable.”); see generally IVERSEN, supra note 12, at 5, 
115–86. Various reports have also indicated that, despite efforts to avoid 
contamination, marijuana sold in states such as Colorado and California have 
been found to contain bacteria, mold, fungi, pesticides, heavy metals, and 
solvents such as butane and propane. See, e.g., Franziska Busse et al., Lead 
Poisoning Due to Adulterated Marijuana, 358 NEW ENGLAND J. MED. 1641 (2008); 
Tista Ghosh et al., The Public Health Framework of Legalized Marijuana in 
Colorado, 106 AM. J. PUB. HEALTH 21, 23 (2016) (“The medical literature reports 
that marijuana can be contaminated by bacteria, mold, chemicals such as 
pesticides, lead, ammonia, and formaldehyde.”) (footnotes omitted); Gourdet et 
al., supra note 64, at 88; Subritzky et al., supra note 6, at 6 (“[T]he presence of 
fungus and residues remains problematic in Colorado”); Contaminated Medical 
Marijuana Believed to Have Killed Cancer Patient, CBS NEWS (Feb. 7, 2017, 11:08 
AM), https://www.cbsnews.com/news/contaminated-medical-marijuana-pot-belie
ved-to-have-killed-cancer-patient/; Brian Handwerk, Modern Marijuana Is Often 
Laced With Heavy Metals and Fungus, SMITHSONIAN (Mar. 23, 2015), 
https://www.smithsonianmag.com/science-nature/modern-marijuana-more-pote
nt-often-laced-heavy-metals-and-fungus-180954696/ (“Concentrates and edibles 
(think brownies) make up perhaps half of the current Colorado market . . . some 
manufacturers employ potentially harmful compounds like butane to strip the 
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harmful substance, as explained above. A “food additive” is 
“any substance the intended use of which results or may 
reasonably be expected to result, directly or indirectly, in its 
becoming a component or otherwise affecting the 
characteristics of any food” unless that substance is 
generally recognized by experts “to be safe under the 
conditions of its intended use.”82 THC certainly satisfies 
 
plant of most everything but THC. Tests also show that marijuana plants can 
draw in heavy metals from the soil in which they are grown, and concentrating 
THC can increase the amounts of heavy metals, pesticides or other substances 
that end up in a product. ‘People use all kinds of different methods to produce 
concentrates,’ [Andy] LaFrate [founder of a laboratory certified to test cannabis] 
says. ‘They allow people to use rubbing alcohol and heptane. But what grade of 
solvents are they using? Are they buying heptane on eBay, and if so, what exactly 
is in there? There are a whole bunch of issues to figure out, and right now there 
are not enough resources and really no watchdog.’”); Brian Melley, Burners 
Beware: California Pot Sold Jan. 1 Could be Tainted, ABC NEWS (Dec. 17, 2017), 
http://abcnews.go.com/Technology/wireStory/burners-beware-california-pot-sold-
jan-tainted-51846148 (“Any marijuana sold when recreational sales become legal 
Jan. 1 in the nation’s most populous state will have been grown without 
regulatory controls that will eventually be in place. Pot could contain pesticides, 
molds and other contaminants. ‘Buyer beware,’ cautioned Donald Land, a 
University of California, Davis, chemistry professor who is the chief scientific 
consultant at Steep Hill Labs Inc., which tests marijuana in several states. 
Earlier this year, Land oversaw testing that found 93 percent of samples collected 
by KNBC-TV from 15 dispensaries in four Southern California counties tested 
positive for pesticides. That may come as a surprise for consumers who tend to 
trust what’s on store shelves because of federal regulations by the U.S. 
Agriculture Department or the U.S. Food and Drug Administration. 
‘Unfortunately, that’s not true of cannabis,’ Land said. ‘They wrongly assume it’s 
been tested for safety.’”); Lynne Peeples, Marijuana Pesticide Contamination 
Becomes Health Concern as Legalization Spreads, HUFFINGTON POST (May 24, 
2013; 7:44 AM), https://www.huffingtonpost.com/2013/05/24/marijuana-
pesticides-contamination_n_3328122.html. 
 82. 21 U.S.C. § 321(s) (“The term ‘food additive’ means any substance the 
intended use of which results or may reasonably be expected to result, directly or 
indirectly, in its becoming a component or otherwise affecting the characteristics 
of any food (including any substance intended for use in producing, 
manufacturing, packing, processing, preparing, treating, packaging, 
transporting, or holding food; and including any source of radiation intended for 
any such use), if such substance is not generally recognized, among experts 
qualified by scientific training and experience to evaluate its safety, as having 
been adequately shown through scientific procedures (or, in the case of a 
substance used in food prior to January 1, 1958, through either scientific 
procedures or experience based on common use in food) to be safe under the 
conditions of its intended use; except that such term does not include—(1) a 
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those requirements. It is intended to become, and in fact 
becomes, a component of an edible, and it has not been 
proven to be safe. On the contrary, the FDA has concluded 
that marijuana is not safe for use in any capacity. In fact, 
Congress resolved that issue as a matter of law when it 
placed marijuana in Schedule I of the Controlled Substances 
Act, the category for drugs that, inter alia, pose a danger to 
human health.83 That conclusion effectively ends the inquiry. 
A state recreational marijuana law offers no shield against 
enforcement of federal law, and the appropriations rider 
noted above does not apply to recreational marijuana 
programs or to the FDA. Accordingly, the FDCA empowers 
the FDA to intervene against the sale of edibles. 
However unusual it may seem, prohibiting edibles 
alone—that is, without also prosecuting the sale of 
marijuana to be smoked—is not an irrational choice, given 
the marijuana regulatory regime we have today. Because 
marijuana is contraband under federal law, the FDA and 
Justice Department could seize any ingestible or inhalable 
marijuana products that may be sold under state law, as well 
as shut down the dispensary itself. To date, the FDA and the 
Justice Department have not pursued that strategy, 
preferring to focus on sham distribution schemes and sales 
to minors. If the government decides to continue with that 
approach, it could readily pursue administrative, civil, and 
criminal actions against the sale of edibles, given the 
certainty that, as a practical matter, edibles will wind up in 
the hands of minors. The result would be that the 
government could shut down the distribution of THC-infused 
foods, while allowing marijuana to be sold in non-edible 
 
pesticide chemical residue in or on a raw agricultural commodity or processed 
food; or (2) a pesticide chemical; or (3) a color additive; or (4) any substance used 
in accordance with a sanction or approval granted prior to September 6, 1958, 
pursuant to this chapter, the Poultry Products Inspection Act [21 U.S.C.A. § 451 
et seq.] or the Meat Inspection Act of March 4, 1907, as amended and extended 
[21 U.S.C.A. § 601 et seq.]; (5) a new animal drug; or (6) an ingredient described 
in paragraph (ff) in, or intended for use in, a dietary supplement.”). 
 83. Larkin, Drugged Driving, supra note 4, at 460 & n.27. 
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forms, as a way to lessen the risk that minors, particularly 
children, will consume attractive, innocent-looking brownies, 
candies, and the like.84 
To be sure, this two-pronged approach is an odd way to 
approach this problem. Stopping the commercial production 
of edibles would drive some people to make their own—where 
there is no quality control—and some others to smoke 
marijuana—which creates its own set of problems. As long 
as the concentrated form of marijuana is available, some 
people will make their own edibles. (That is particularly true 
if, as seems likely, the price of concentrate will fall, due to a 
decreased demand, if edibles are banned.) The result will be 
a lack of statewide quality control, which increases the risk 
of an unintentional overdose, particularly by minors who are 
amateur chefs—and amateur chemists—as well as a greater 
risk of consuming a product contaminated with various 
toxins. If people switch to smoking marijuana, there are 
other risks. No other drug is smoked because smoking does 
not guarantee that a predetermined amount of a medicine 
will be delivered to the body—for example, there is no 
uniform number of “puffs” or depth of an individual puff—
and smoking marijuana carries with it many of the harms of 
smoking tobacco—for example, it irritates the lung tissues. 
Nonetheless, like all compromise solutions, this one is not 
perfect, but it does address one fear that society has. 
Why then has the FDA not taken any step to halt the 
distribution of edibles since California enacted the first 
medical marijuana law in 1996? Three explanations come to 
mind. 
One is that the FDA decided to leave the entire subject 
of marijuana to the federal law enforcement agencies 
because the Controlled Substances Act deems marijuana 
contraband.85 That is, the FDA saw no reason to regulate the 
 
 84. A narrower option would be to stop the interstate distribution of sweetened 
edibles, given that a high sugar content may attract children. 
 85. The Controlled Substances Act was enacted as Title II of the 
350 BUFFALO LAW REVIEW [Vol. 66 
sale of a drug that cannot be lawfully sold.86 That 
explanation makes sense on its face, but is ultimately flawed 
in the case of edibles. A rule prohibiting a particular 
substance from being added to food is a form of regulation, 
but it does not imply that all other substances are 
permissible additives. In other words, the directive, “you may 
not add A to food,” does not imply that B, C, and the other 
letters in the alphabet can be included in a food product sold 
to the public. To eliminate any doubt, the FDA could make 
that point in the same rule banning the sale of edibles.87 
The second reason may be that the agency chose to avoid 
becoming involved in the battles over the proper federal 
 
Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. No. 91-
513, 84 Stat. 1236. Under that act, a “controlled substance” is “a drug or other 
substance, or immediate precursor, included in schedule I, II, III, IV, or V of part 
B of this title,” except for “distilled spirits, wine, malt beverages, or tobacco, as 
those terms are defined or used in subtitle E of the Internal Revenue Code of 
1954.” 21 U.S.C. § 802(6) (2012). The Controlled Substances Act incorporates the 
definition of a “drug” from the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 
§ 201 (g)(1) (2017). Congress placed marijuana in Schedule I when it enacted the 
Controlled Substances Act. See Alliance for Cannabis Therapeutics v. DEA, 930 
F.2d 936, 937 n.1 (D.C. Cir. 1991). Marijuana (and its salts, isomers, and 
synthetic equivalents) remains on that list today. 21 C.F.R. § 1308.11(d)(31) 
(2017). Drugs placed on Schedule I drugs are one found to have no accepted 
medical use and pose a serious danger of harm and addiction. Physicians cannot 
prescribe Schedule I drugs. Larkin, Drugged Driving, supra note 4, at 460 & 
nn.26–27. 
 86. MacCoun & Mello, supra note 8, at 990. 
 87. The FDA could say something like this: 
Section 1: Because THC and other ingredients in marijuana can have 
adverse effects on people, food products, commonly known as ‘edibles,’ 
cannot be distributed in interstate commerce if they contain THC or 
other cannabinoids found in marijuana. Section 2: The ban in Section 1 
on the use of THC or other cannabinoids in food is not a license or 
approval to distribute those substances in interstate commerce in any 
other manner. 
An agency generally has the last word on the meaning of its own regulations 
unless its reading is inconsistent with the text of the rule. Under settled law, 
when an agency’s interpretation of its own regulation is at stake, “the ultimate 
criterion is the administrative interpretation, which becomes of controlling 
weight unless it is plainly erroneous or inconsistent with the regulation.” See 
Bowles v. Seminole Rock & Sand Co., 325 U.S. 410, 414 (1945); accord, e.g., Auer 
v. Robbins, 519 U.S. 452, 461 (1997) (reaffirming the Seminole Rock standard). 
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response to state marijuana legalization. Current 
legalization proposals focus on the recreational use of 
marijuana, but the initial proposals sought only to permit 
marijuana to be used as a “treatment” for various afflictions. 
Supporters of medical marijuana argued that it could help 
alleviate the suffering of the dying or grievously impaired, 
particularly when smoked.88 They pointed to individuals 
disabled by chemotherapy-induced nausea and vomiting, the 
weight loss associated with HIV/AIDS, the neuropathic pain 
and spasticity afflicting victims of multiple sclerosis, the 
chronic pain in adults that over-the-counter analgesics 
cannot assuage, and the sleep disturbances that are 
consequent upon several different diseases.89 Supporters 
also argued that it is irrational to be worried about long-term 
health problems for someone who is in the end stages of a 
terminal disease or is presently suffering from the type of 
intractable pain, nausea, and vomiting that would make 
anyone wish that death were near.90 The FDA may have 
decided that Presidents Clinton, Bush, and Obama were 
unwilling to endure the political blowback that would result 
from armed federal agents seizing marijuana from hospices 
and homes that would be displayed all-day across television 
screens. The FDA may have feared that intervening in this 
fray would lead to irreparable damage to its authority and 
image from being chastened by the media and corralled by 
the president, and perhaps, Congress. The FDA may have 
 
 88. Smoked plant-form marijuana, supporters contend, is superior to other, 
synthetic THC delivery vehicles (e.g., pills, inhalants, and suppositories) 
approved by the U.S. Food and Drug Administration (e.g., Dronabinol) or other 
nations (e.g., Nabiximol) because inhalation works more effectively and more 
quickly, reaching the brain within seconds. See, e.g., NAT’L ACAD. REP., supra note 
5, at 54; IVERSEN, supra note 12, at 45–47. 
 89. See, e.g., NAT’L ACAD. REP., supra note 5, at 128 (listing conditions for 
which marijuana is a treatment for which there are varying degrees of scientific 
support); IVERSEN, supra note 12, at 131, 140–48, 162; Volkow et al., supra note 
28, at 2224 (listing clinical conditions with symptoms marijuana may alleviate); 
supra note 28. 
 90. See, e.g., Jerome P. Kassirer, Federal Foolishness and Marijuana, 336 
NEW ENG. J. MED. 366, 366 (1997). 
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decided to wait until it was sure that the political branches 
would support its intervention. 
That wait may not yet be over. The federal political 
branches have yet to decide on the appropriate federal 
response to state marijuana legalization. Congress has 
largely stayed out of the debate. With the one exception 
adumbrated above and discussed below regarding the 
Justice Department’s prosecution policies, Congress has 
studiously avoided any serious debate over the legality of 
medical or recreational marijuana. As far as the executive 
branch goes, the administrations of former Presidents Bill 
Clinton, George W. Bush, and Barack Obama did not come 
to a settled position. From 1996, when California adopted the 
first medical marijuana initiative, through the end of the 
Obama Administration, the Justice Department has gone 
back and forth on the issue of whether it should prosecute 
the sale of marijuana in states with medical and recreational 
marijuana régimes. In fact, the initial response, set forth 
early in 1997, only three months after California passed its 
medical marijuana initiative, by Barry McCaffrey, the high-
profile Director of the Office of National Drug Control Policy 
in the Clinton Administration, was to threaten any physician 
who prescribed marijuana for a patient with the loss of his 
license to prescribe controlled substances.91 The Clinton and 
Bush Administrations also signaled that they would ignore 
the state liberalization measures and prosecute businesses 
distributing cannabis.92 By contrast, the Obama 
Administration adopted a policy of largely declining to 
enforce federal law against patients, caregivers, and 
recreational users and of focusing on businesses engaged in 
 
 91. McCaffrey made that point in no uncertain terms. See Administration 
Response to Arizona Proposition 200 and California Proposition 215, 62 Fed. Reg. 
6164, 6164 (Feb. 11, 1997) (warning that the “DEA will seek to revoke the DEA 
registrations of physicians who recommend or prescribe Schedule I controlled 
substances”). 
 92. Larkin, Drugged Driving, supra note 4, at 469. 
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large-scale trafficking in cannabis or the sale to minors.93 
Indeed, the growth in states’ medical marijuana programs 
coincides with the release in October 2009 of a memorandum 
signed by Deputy Attorney General David Ogden—known as 
the Ogden Memorandum—announcing a policy that was 
seen as a hands-off approach toward the sale of medical 
marijuana in compliance with state law, while the growth in 
recreational marijuana laws resulted from the 2013 Cole 
Memorandum, which signaled that the Justice Department 
would take the same approach toward state recreational 
marijuana programs as long as they were applied in 
accordance with state law.94 The Justice Department 
represented the FDA in federal court,95 so it may have made 
little sense to the agency to adopt a position treating edibles 
as adulterated under the FDCA if the Justice Department 
would not defend that position in court. 
It is unclear what will happen now. In 2017, Attorney 
 
 93. See Memorandum from James M. Cole, Deputy Att’y Gen., U.S. Dep’t of 
Justice, for United States Attorneys on Guidance Regarding Marijuana 
Enforcement (Aug. 29, 2013); Memorandum from David W. Ogden, Deputy Att’y 
Gen., U.S. Dep’t of Justice, for Selected United States Attorneys on Investigations 
and Prosecutions in States Authorizing the Medical Use of Marijuana (Oct. 19, 
2009); see also Memorandum from James M. Cole, Deputy Att’y Gen., U.S. Dep’t 
of Justice, for United States Attorneys on Guidance Regarding Marijuana 
Related Financial Crimes (Feb. 14, 2014); Memorandum from James M. Cole, 
Deputy Att’y Gen., U.S. Dep’t of Justice, for United States Attorneys on Guidance 
Regarding the Ogden Memo in Jurisdictions Seeking to Authorize Marijuana for 
Medical Use (June 30, 2011); BARCOTT, supra note 55, at 65. 
 94. See Monte et al., supra note 5, at 241 (“Few patients used medical 
marijuana until October 2009, when the US Attorney General distributed 
guidelines for federal prosecution of the possession and use of marijuana, ceding 
jurisdiction of marijuana law enforcement to state governments. The combination 
of permissive local law and the federal policy change effectively liberalized the 
sale and use of medical marijuana in Colorado. Anyone with one of the conditions 
outlined by Colorado law could be issued a medical marijuana license with no 
expiration date. The number of licenses increased from 4819 on December 30, 
2008, to 116 287 on September 30, 2014.”); Onders, supra note 30, at 433; Wang 
et al., Multistate Study 2005–2011, supra note 14, at 688. 
 95. See 28 U.S.C. §§ 503, 506, 509–519 (2006) (authorizing the Attorney 
General to supervise all federal litigation); FDA ENFORCEMENT MANUAL ¶ 1220 
(2015). 
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General Jeff Sessions said that the widespread sale of 
marijuana was harmful for the nation, which indicated a 
willingness to reconsider the enforcement positions of his 
predecessors.96 On January 4, 2018, he decided to revisit the 
Justice Department’s policy and both the Cole and Ogden 
Memoranda.97 The Sessions Memorandum stated that U.S. 
Attorneys should make charging decisions based on the 
seriousness of marijuana trafficking in their respective 
jurisdictions.98 
The 2018 Sessions Memorandum does not indicate that 
it will be the only change in marijuana policy that we may 
see in the Trump Administration. Sessions may not attempt 
to fully return the department to the position that it held 
prior to the post-1996 state marijuana reform efforts, but 
there is additional room for him to expand the department’s 
efforts to suppress large-scale commercial marijuana 
operations. If he does, he may decide to enlist the FDA’s 
support, and, if he does, that would prevent the FDA from 
standing on the sidelines. A formal declaration by Attorney 
General Sessions that the executive branch will aggressively 
pursue civil and criminal enforcement actions against the 
distribution of marijuana edibles under the Controlled 
Substances Act and FDCA would force the FDA to take a 
position on one side or the other regarding its enforcement 
authority and priorities. That might lead President Trump 
and Congress to enter the fray as well. 
Regardless of what executive branch officials decide to 
do, marijuana legalization’s supporters will pressure 
 
 96. See, e.g., Tom Angell, Jeff Sessions Slams Marijuana Legalization (Again), 
FORBES (Sept. 27, 2017), https://www.forbes.com/sites/tomangell/2017/09/20/jeff-
sessions-slams-marijuana-legalization-again/#3afea92a27d1. 
 97. Press Release, U.S. Dep’t of Justice, Marijuana Enforcement (Aug. 29, 
2013) (on file with author), https://www.justice.gov/opa/press-release/file/
1022196/download; see Charlie Savage & Jack Healy, Trump Administration 
Takes Step That Could Threaten Marijuana Legalization Movement, N.Y. TIMES 
(Jan. 4, 2018), https://www.nytimes.com/2018/01/04/us/politics/marijuana-
legalization-justice-department-prosecutions.html. 
 98. See Press Release, U.S. Dep’t of Justice, supra note 97. 
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Congress to halt any aggressive use of federal law to stem 
the sale of edibles. Marijuana legalization is potentially a 
huge business for private parties and a new source of 
revenue for states. Estimates are that marijuana legalization 
will generate thousands of jobs, along with billions of dollars 
in revenues for private parties and state governments over 
the next few years.99 People who stand to make or lose that 
 
 99. See, e.g., Debra Borchardt, Marijuana Industry Projected to Create More 
Jobs than Manufacturing by 2020, FORBES (Feb. 22, 2017), 
https://www.forbes.com/sites/debraborchardt/2017/02/22/marijuana-industry-
projected-to-create-more-jobs-than-manufacturing-by-2020/ (“A new report from 
New Frontier Data projects that by 2020 the legal cannabis market will create 
more than a quarter of a million jobs. This is more than the expected jobs from 
manufacturing, utilities or even government jobs, according to the Bureau of 
Labor Statistics. The BLS says that by 2024 manufacturing jobs are expected to 
decline by 814,000, utilities will lose 47,000 jobs and government jobs will decline 
by 383,000. This dovetails with data that suggests the fastest-growing industries 
are all healthcare related. The legal cannabis market was worth an estimated 
$7.2 billion in 2016 and is projected to grow at a compound annual rate of 17%. 
Medical marijuana sales are projected to grow from $4.7 billion in 2016 to $13.3 
billion in 2020. Adult recreational sales are estimated to jump from $2.6 billion 
in 2016 to $11.2 billion by 2020.”); Rory Campbell, Hippy Dream Now a Billion-
Dollar Industry with California Set to Legalize Cannabis, GUARDIAN (Dec. 30, 
2017), https://amp.theguardian.com/us-news/2017/dec/30/california-legalise-can
nabis-hippy-dream-billion-dollar-industry (“The Salinas Valley, an agricultural 
zone south of San Francisco nicknamed America’s salad bowl, has already earned 
a new moniker: America’s cannabis bucket. Silicon Valley investors and other 
moneyed folk are hoping to mint fortunes by developing technology to cultivate, 
transport, store and sell weed. Entrepreneurs are devising pot-related products 
and services. Financiers are exploring ways to fold the revenue – estimated at 
$7bn per annum by 2020—into corporate banking.”); Chris Morris, Legal 
Marijuana Sales Are Expected to Hit $10 Billion This Year, FORTUNE (Dec. 6, 
2017), http://fortune.com/2017/12/06/legal-marijuana-sales-10-billion/; Aaron 
Smith, Market for Legal Pot Could Pass $20 Billion, CNN MONEY (Nov. 11, 2017, 
7:08 AM), http://money.cnn.com/2016/11/09/news/economy/marijuana-legalizat
ion-sales/index.html (“Voters in four states approved legal recreational pot on 
Tuesday. Four more states expanded access to medical marijuana. All told, it 
could expand the national market to $21 billion by 2020, according to New 
Frontier Data, which partnered with the marijuana industry organization 
Arcview Group. That is up from $5.7 billion last year and an expected $7.9 billion 
this year.”); Aaron Smith, Colorado Passes a Milestone for Pot Revenue, CNN 
MONEY (July 19, 2017, 2:52 PM), http://money.cnn.com/2017/07/19/news/
colorado-marijuana-tax-revenue/index.html (“VS Strategies, a pro-legalization 
research company in Denver, says that the state has pulled in $506 million since 
retail revenues began in January 2014. . . . Revenue from taxes and fees has 
increased each year, from $76 million in 2014 to $200 million last year, and the 
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much money are not likely to watch idly as elected federal 
officials decide what to do. If they are not already making 
their voices heard in Congress—especially to members of the 
California delegation—they will.100 
The third reason why the FDA may have chosen to stand 
on the sidelines is that the federal government may have 
broadly read an appropriations rider restricting the Justice 
Department from nullifying state medical marijuana 
programs. As explained above, in 2014, Congress added a 
provision to the Consolidated and Further Continuing 
Appropriations Act of 2015, prohibiting the Department of 
Justice from using federal funds to “prevent such States from 
implementing their own State laws that authorize the use, 
distribution, possession, or cultivation of medical 
marijuana.”101 The U.S. Court of Appeals for the Ninth 
Circuit construed that provision in 2016 in a case involving 
large-scale traffickers, United States v. McIntosh.102 The 
 
state is on track to beat that this year, according to VS Strategies, which used 
state revenue data in its report Wednesday.”). 
 100. See Morris, supra note 99 (“California’s medical marijuana market is 
already as big as the total markets in Colorado, Washington, and Oregon 
combined, according to BDS Analytics’ GreenEdge point-of-sale tracking service. 
Given the boost from that state and others that could change their laws (including 
New Jersey), Arcview says that it expects the legal cannabis market to reach 
sales of $24.5 billion by 2021.”). 
 101. See Consolidated and Further Continuing Appropriations Act of 2015, 
supra note 75. 
 102. 833 F.3d 1163 (9th Cir. 2016). The facts were the following: 
In McIntosh, five codefendants allegedly ran four marijuana stores in 
the Los Angeles area known as Hollywood Compassionate Care (HCC) 
and Happy Days, and nine indoor marijuana grow sites in the San 
Francisco and Los Angeles areas. These codefendants were indicted for 
conspiracy to manufacture, to possess with intent to distribute, and to 
distribute more than 1000 marijuana plants in violation of 21 U.S.C. §§ 
846, 841(a)(1), 841(b)(l)(A). The government sought forfeiture derived 
from such violations under 21 U.S.C. § 853. In Lovan, the U.S. Drug 
Enforcement Agency and Fresno County Sheriff’s Office executed a 
federal search warrant on 60 acres of land located on North Zedicker 
Road in Sanger, California. Officials allegedly located more than 30,000 
marijuana plants on this property. Four codefendants were indicted for 
manufacturing 1000 or more marijuana plants and for conspiracy to 
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defendants argued that the rider barred the government 
from prosecuting them for any marijuana-related offense 
because they were licensed under California and Washington 
state law to grow and distribute marijuana. McIntosh held 
that the appropriations rider bars the federal government 
from prosecuting someone who fully complies with the 
medical marijuana laws in his state. The court reasoned 
that, “[i]f the federal government prosecutes such 
individuals, it has prevented the state from giving practical 
effect to its law providing for non-prosecution of individuals 
who engage in the permitted conduct.”103 During the Obama 
Administration, the Justice Department might have 
concluded that the McIntosh case was correctly decided. If so, 
the department read that case too broadly. 
The Ninth Circuit concluded that the California and 
Washington laws sought to immunize parties from a federal 
prosecution if they complied with state law. The relevant 
issue in McIntosh, however, was whether the criminal 
prosecution brought in McIntosh would “prevent” those 
states from “implementing” their medical marijuana 
program. It is difficult to see how any one prosecution would 
“prevent” a state from “implementing” such a program as 
long as other uncharged parties can grow and distribute 
 
manufacture 1000 or more marijuana plants in violation of 21 U.S.C. §§ 
841(a)(1), 846. In Kynaston, five codefendants face charges that arose 
out of the execution of a Washington State search warrant related to an 
investigation into violations of Washington’s Controlled Substances Act. 
Allegedly, a total of 562 ‘growing marijuana plants,’ along with another 
677 pots, some of which appeared to have the root structures of 
suspected harvested marijuana plants, were found. The codefendants 
were indicted for conspiring to manufacture 1000 or more marijuana 
plants, manufacturing 1000 or more marijuana plants, possessing with 
intent to distribute 100 or more marijuana plants, possessing a firearm 
in furtherance of a Title 21 offense, maintaining a drug-involved 
premise, and being felons in possession of a firearm in violation of 18 
U.S.C. §§ 922(g)(1), 924(c)(1)(A)(i) and 21 U.S.C. §§ 841, 856(a)(1). 
Id. at 1169. 
 103. Id. at 1177. 
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marijuana.104 In any event, the purpose of the rider is to keep 
the Justice Department from bringing a criminal prosecution 
against someone involved in the distribution of medical 
marijuana, not recreational marijuana. The omission of the 
latter is significant because Congress certainly knows about 
the difference and, by declining to keep the Justice 
Department from charging people or businesses involved in 
recreational marijuana sales, did not intend to prevent the 
Justice Department from prosecuting the latter. 
Legalization’s supporters will argue that, although the 
Rohrabacher Amendment does not specifically refer to the 
FDA, the Justice Department is the FDA’s lawyer, and the 
amendment limits the department’s ability to represent its 
client. That is, the argument will be that the amendment 
should not be limited to keeping the Justice Department 
from bringing criminal prosecutions or asset-forfeiture 
proceedings, but should also be read to bar the department’s 
 
 104. There is an additional factor to consider—namely, the appropriations 
rider cannot be read broadly. A government official who violates an 
appropriations law limitation can be criminally prosecuted for his actions under 
the Antideficiency Act. See 31 U.S.C. § 1341(a)(1)(A) (2012) (“An officer or 
employee of the United States Government or of the District of Columbia 
government may not . . . make or authorize an expenditure or obligation 
exceeding an amount available in an appropriation or fund for the expenditure 
or obligation . . . .”); 31 U.S.C. § 1350 (“An officer or employee of the United States 
Government or of the District of Columbia government knowingly and willfully 
violating section 1341(a) or 1342 of this title shall be fined not more than $5,000, 
imprisoned for not more than 2 years, or both.”). The appropriations rider has the 
effect of a criminal law, which means it cannot be read broadly and any doubt as 
to its meaning must be resolved by application of the Rule of Lenity. See, e.g., 
United States v. Santos, 553 U.S. 507, 514 (2008) (plurality opinion); Paul J. 
Larkin, Jr., Chevron and Federal Criminal Law, 33 J. L. & POL. 211, 228–29 
(2017). That is significant because the term “prevent” can be read narrowly, as 
meaning to “avert” or “keep [something] from occurring,” or broadly, as including 
an action that “hinders” someone from acting. See Dictionary.com (“prevent”: 
“verb (used with object) 1. to keep from occurring; avert; hinder: He intervened 
to prevent bloodshed. 2. to hinder or stop from doing something: There is nothing 
to prevent us from going. 3. Archaic. to act ahead of; forestall. 4. Archaic. to 
precede. 5. Archaic. to anticipate.”). Prevent, DICTIONARY.COM, 
http://www.dictionary.com/browse/prevent?s=t (last visited Feb. 17, 2018). 
Because the Antideficiency Act is a criminal statute, the term “prevent” should 
be narrowly read to mean “halt,” not broadly to include “hinder.” 
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lawyers from representing the FDA in any action that would 
have the effect of shutting down a state’s medical marijuana 
regime. The purpose of the Rohrabacher Amendment is to 
allow states to decide whether to operate medical marijuana 
programs without fear that the Justice Department will use 
its litigating authority to shut down any such operation. 
Accordingly, the amendment should be construed broadly so 
that it prohibits Justice Department lawyers from 
representing the FDA if it were to bring an enforcement 
action against a business on the ground that it sold 
marijuana edibles that were adulterated or misbranded. 
That argument is inventive, but ultimately is 
unpersuasive. 
Start with the fact that the Rohrabacher Amendment 
does not repeal or revise the FDCA, nor does it limit what 
the FDA can do with its appropriated funds. The amendment 
therefore does not affect the ability of the FDA to pursue 
whatever steps it can independently take to prevent the 
distribution of adulterated foods in interstate commerce. 
Given that Congress has not forbidden the FDA from taking 
action under the FDCA against adulterated or misbranded 
food products, it is unreasonable to construe the 
Rohrabacher Amendment as limiting the FDA’s authority to 
protect the public health. After all, it is the FDA’s mission to 
prevent adulterated or misbranded food products from 
entering the stream of commerce. The Justice Department is 
merely the agency’s lawyer. 
That distinction is an important one. It was not the fear 
of actions potentially undertaken by the FDA to prevent the 
distribution of adulterated or misbranded food or drugs that 
lead Representative Dana Rohrabacher to propose, and 
Congress to adopt the Rohrabacher Amendment; nor was it 
the Justice Department’s role as the FDA’s in-court counsel 
that saw to the amendment’s passage. It was the fear of 
armed federal agents arresting seriously ill medical patients 
and removing them from their homes, nursing facilities, or 
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hospices.105 In some instances, that was more than a mere 
“fear.” In 2002, Drug Enforcement Administration agents 
entered the home of a medical marijuana patient and seized 
six marijuana plants. As one commentator put it: 
 
 105. See Rohrabacher, supra note 75 (“I wrote an amendment to spending bills 
that prohibits the federal government from prosecuting medical marijuana cases 
in states where voters have legalized such treatment.”); Alex Kreit, Beyond the 
Prohibition Debate: Thoughts on Federal Drug Laws in an Age of State Reforms, 
13 CHAPMAN L. REV. 555, 569–70 (2010) (“Between them, [Gonzales v. Raich, 545 
U.S. 1 (2005) and United States v. Oakland Cannabis Buyers’ Coop., 532 U.S. 
483, 494–95 (2001)] left little doubt that federal officials could constitutionally 
prosecute medical marijuana growers, providers, and even patients themselves. 
And, throughout the past decade, the federal government enthusiastically 
exercised this authority, at least in California. It has raided at least 190 medical 
marijuana collectives and brought criminal charges against medical marijuana 
growers and collective operators, many of whom were operating in strict 
compliance with California’s law. In one high profile prosecution, for example, 
the federal government obtained a conviction against Charlie Lynch, who 
operated a medical marijuana collective in Morro Bay, California. Lynch had the 
backing of town officials and even held a ribbon-cutting ceremony attended by 
the mayor and members of the city council when he opened up shop. At his 
sentencing, District Court Judge George H. Wu indicated some displeasure with 
having to impose a one-year jail sentence for Lynch. The New York Times 
reported that Wu ‘talked at length about what he said were Mr. Lynch’s many 
efforts to follow California’s laws on marijuana dispensaries’ before concluding: ‘I 
find I cannot get around the one-year sentence . . . .’ The DEA has even gone after 
landlords who have knowingly rented their property to medical marijuana 
collective operators and growers through asset forfeiture proceedings.”) 
(footnotes omitted); Zach Harris, A Brief History of Rohrabacher-Farr: The 
Federal Amendment Protecting Medical Marijuana, MERRY JANE (Dec. 19, 2017), 
https://merryjane.com/news/a-brief-history-of-rohrabacher-farr-the-federal-
amendment-protecting-medical-marijuana (“[T]he Rohrabacher-Farr 
amendment . . . prevents the Department of Justice from spending federal funds 
to prosecute cannabis-related activities if they are permitted under state-specific 
medical marijuana laws.”); Michael M. O’Hear, Federalism and Drug Control, 57 
VAND. L. REV. 783, 840 n.322 (2004) (“Federal agents have raided medical 
marijuana distribution organizations in West Hollywood, San Francisco, 
Oakland, and Sebastopol.”); Maria Alicia Gaura, Santa Cruz Officials Fume over 
Medical Pot Club Bust/DEA Arrests Founders, Confiscates Plants, S.F. CHRON. 
(Sept. 6, 2002), http://www.sfgate.com/bayarea/article/Santa-Cruz-officials-fume-
over-medical-pot-club-2773777.php; Charlie LeDuff & Adam Liptak, Defiant 
California City Hands Out Marijuana, N.Y. TIMES (Sept. 18, 2002), 
http://www.nytimes.com/2002/09/18/us/defiant-california-city-hands-out-mariju
ana.html; cf. Gonzales v. Raich, 545 U.S. 1 (2005) (lawsuit brought against the 
attorney general and the DEA to enjoin the enforcement of the federal controlled 
substances laws against the use of home-grown marijuana for medical purposes); 
supra notes 7, 69 & 71. 
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When thirty federal Drug Enforcement Administration (DEA) 
agents armed with M-16s burst into a medical marijuana hospice in 
Santa Cruz, California, on September 5, 2002, arresting the two 
owners and a wheelchair-bound patient disabled by polio, they 
propelled an already contentious debate between the federal 
government and state leaders to new heights.106 
Those events in a California town could not have been lost on 
Dana Rohrabacher, a Congressman from California, when he 
offered his amendment. That fear still resonates today.107 
 
 106. Alex Kreit, Comment, The Future of Medical Marijuana: Should the 
States Grow Their Own?, 151 U. PA. L. REV. 1787, 1787 (2003) (footnotes omitted); 
see also, e.g., HUDAK, supra note 15, at 141 (“[T]he Clinton and George W. Bush 
administrations tried to enforce federal law, authorizing the DEA and the FBI to 
work with local law enforcement to raid medical marijuana operations across the 
American West. Grow operations and processors were shut down. Co-op 
participants were handcuffed and assets were seized. Anecdotes abound of 
terminally ill patients being treated like street criminals for being caught tending 
their plants when federal agents arrived”). That incident sparked considerable 
political protest in California. Kreit, supra, at 1787–88 (“In response, Santa Cruz 
officials, who had ‘cooperated closely’ with the hospice for six years, ’issued a 
provocative public challenge’” to the DEA by organizing an event to distribute 
medical marijuana on the steps of City Hall. Mayor Christopher Krohn, who 
attended the event alongside city council members, said that ‘[c]learly, state law 
and federal law are on a collision course’ and vowed to stand by the hospice until 
federal law changed. Vice-Mayor Emily Reilly went even further, calling it 
‘absolutely loathsome . . . that federal money, energy and staff time would be 
used to harass people like this. . . . The outrage spread quickly from Santa Cruz 
to other parts of California. Patients organized protests across the state, and 
‘State Attorney General Bill Lockyer protested and demanded a meeting with 
[U.S. Attorney General John] Ashcroft.’ Just a few weeks after the Santa Cruz 
City Hall event, San José Police Chief William Lansdowne removed his officers 
from the DEA’s High Intensity Drug Trafficking Area task force in protest. 
Officials in other California cities followed San José’s lead and asked their police 
officers to ‘stop cooperating with federal agents.’”) (footnotes omitted); 
Christopher Krohn, Opinion, Why I’m Fighting Federal Drug Laws from City 
Hall, N.Y. TIMES, Sept. 21, 2002, at A15 (“How did I, a mayor of a small town in 
California, wind up in a tug of war with the Drug Enforcement Agency? This 
week, I stood in front of Santa Cruz’s city hall as a local group that provides 
medical marijuana went about its weekly task of distributing the drug to the sick 
and dying. . . . My story begins on the morning of Sept. 5 when approximately 30 
men, dressed in military fatigues and carrying automatic weapons, descended on 
a small cooperative farm run by the Wo/Men’s Alliance for Medical Marijuana in 
northern Santa Cruz County, about 65 miles south of San Francisco.”). 
 107. See, e.g., Robin Abcarian, Drug War Overkill: A Post Bust against Legal 
Growers in Yolo County Seems to Go Too Far, L.A. TIMES (Jan. 6, 2017), 
http://www.latimes.com/local/abcarian/la-me-abcarian-pot-bust-20170106-
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It is important to remember that protecting the public 
against adulterated food is one of the FDA’s historic 
missions. This task originated in the Pure Food and Drug Act 
of 1906.108 Signed into law by President Theodore Roosevelt 
on the same day that he signed the companion bill, Federal 
Meat Inspection Act of 1906,109 the Pure Food and Drug Act 
was a response to “extensive evidence of product adulteration 
and industrial fraud,” as described in Upton Sinclair’s novel 
 
story.html (“I sat with Hicks and Mears on Wednesday in the office of their 
Sacramento attorney, Mark Reichel, and both grew tearful as they recalled the 
terror they felt when dozens of gun-wielding officers pounded on their front doors 
the morning of Sept. 14. ‘I told my 2-year-old son to stay upstairs,’ said Mears, 
35. ‘When I opened the security door, there were 15 cops with assault rifles 
drawn, pointed, with their fingers on the trigger, in vests, ski masks. They 
grabbed me and pulled me out front, put me in handcuffs. There were 20 to 30 
officers. My son walked downstairs and my wife had to grab him. They had guns 
pulled on them. It was real painful. Easily, it was the worst day of my life,’ said 
Hicks, 43. ‘Every gun you can imagine was pointed at me. I was like, ‘Why is this 
happening?’ To add icing to the cake, it was my son’s fourth birthday.’”); Thomas 
Fuller, Medical Marijuana Is Legal in California. Except When It’s Not, N.Y. 
TIMES (Nov. 21, 2016), https://www.nytimes.com/2016/11/22/us/medical-mariju
ana-is-legal-in-california-except-when-its-not.html (“CannaCraft produces 
medical marijuana products, which have been legal in the state for two decades, 
but operated in a kind of Wild West, unregulated market. In June, the company’s 
newly opened headquarters was raided by federal and local law enforcement 
officers, who said the process it used to make marijuana products was dangerous 
and illegal. . . . In May, the company hosted nearly 50 state lawmakers and 
regulators from Sacramento, the state capital, to demonstrate the process it uses 
to produce the soft-gel capsules and other cannabis-based products that do not 
involve smoking. . . . But two weeks after the visit . . . around 100 officers and 
agents wearing tactical gear, and representing multiple law enforcement 
agencies, raided the company’s headquarters and four other facilities.”); 
Angelique Moss, Collision of Federal and State Laws about Medical Marijuana 
Threatens to Make Patients, Legal ‘Casualties,’ POLICY (May 15, 2016), 
https://thepolicy.us/collision-of-federal-and-state-laws-about-medical-marijuana-
threatens-to-make-patients-legal-483a0865e738 (“The growth, manufacture, and 
distribution of medical marijuana have all been legalized in 24 U.S. states, but 
current federal laws which prohibit their use are placing well-meaning medical 
marijuana patients and doctors in legal jeopardy. As the Department of Justice, 
politicians, and lawyers on both sides wrestle with the reconciliation and 
resolution of the application of two contradicting laws in one location, the friendly 
neighbor down the street who grows his own cannabis in order to treat his child’s 
epileptic illness can face arrest, prosecution, and possible imprisonment.”). 
 108. Act of June 30, 1906, ch. 3915, Pub. L. No. 59-348, 34 Stat. 786 (1906). 
 109. Act of March 4, 1907, ch. 2907, Pub. L. No. 59-242, 34 Stat. 1256 (1906). 
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The Jungle and other then-contemporary publications.110 
With respect to food, the act provided that “an article shall 
be deemed to be adulterated” if it contained “any added 
poisonous or other added deleterious ingredient which may 
render such article injurious to health,”111 while a food would 
be deemed “misbranded” if it were “labeled or branded so as 
to deceive or mislead the purchaser.”112 To enforce that 
section, the act assigned to the U.S. Department of 
Agriculture’s Bureau of Chemistry, which ultimately became 
the FDA, the responsibility to prevent the shipment of 
adulterated or misbranded foods in interstate commerce by 
inspecting food and drug products and referring violators for 
prosecution.113 The Pure Food and Drug Act “prohibited the 
addition of any ingredients that . . . [would] pose a health 
hazard.”114 When the FDA replaced the Pure Food and Drug 
Act in 1938 with the FDCA, Congress directed the FDA to 
continue the food protection responsibilities of its 
predecessor agency.115 The FDA has carried out that 
 
 110. Ilyse D. Barkan, Industry Invites Regulation, The Passage of the Pure 
Food and Drug Act of 1906, 75 AM. J. PUB. HEALTH 18, 21 (1985) (footnotes 
omitted); see also INST. MED & NAT’L RESEARCH COUNCIL, Ensuring Safe Food 
from Production to Consumption 21–22, 26–27 (1998); Jillian London, Tragedy, 
Transformation, and Triumph: Comparing the Factors and Forces that Led to the 
Adoption of the 1860 Adulteration Act in England and the 1906 Pure Food and 
Drug Act, 69 FOOD & DRUG L. J. 315 (2014). 
 111. Pure Food and Drug Act § 7, 34 Stat. at 769–70 (1906). 
 112. Id. § 8, 34 Stat. at 770. Interestingly, Congress also provided that a food 
was misbranded if it did not “bear a statement on the label of the quantity or 
proportion of” several components that would today be labeled controlled 
substances, including “cannabis indicia.” Id. 
 113. Id. §§ 4–5, 34 Stat. at 769. 
 114. See The 1906 Food and Drugs Act and Its Enforcement, U.S. FOOD & DRUG 
ADMIN., https://www.fda.gov/AboutFDA/WhatWeDo/History/FOrgsHistory/Evolv
ingPowers/ucm054819.htm (last updated Feb. 1, 2018). 
 115. See Food, Drug, and Cosmetic Act of 1938, 21 U.S.C. §§ 321, 331 (2018); 
1938, Food, Drug, Cosmetic Act, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/
AboutFDA/WhatWeDo/History/FOrgsHistory/EvolvingPowers/ucm054826.htm 
(last updated Feb. 1, 2018); Drugs and Foods Under the 1938 Act and Its 
Amendments, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/AboutFDA/What
WeDo/History/FOrgsHistory/EvolvingPowers/ucm055118.htm (last updated Feb. 
1, 2018). Since then, Congress has also enacted the Food Safety Modernization 
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mandate by issuing regulations or guidance documents and 
by taking enforcement action when necessary.116 
That history is particularly important here because the 
appropriations rider does not state or suggest that Congress 
intended to restrict the FDA’s authority to protect the public 
against an unsafe food product. The FDCA and the 
Controlled Substances Act are two entirely separate laws; 
the latter does not refer to the former, let alone expressly 
repeal any portion of it. Accordingly, the appropriations rider 
could limit the FDA’s authority only if it repealed by 
implication the relevant provisions of the FDCA dealing with 
food products. That, however, would be a difficult hurdle to 
overcome. A settled rule of statutory interpretation is that 
two acts of Congress should be construed in a manner that 
harmonizes their operation, rather than conflict with each 
other. The Supreme Court has noted that the “rarity” of 
 
Act, Pub. L. No. 111-353, 124 Stat. 3885 (2011), to enhance the FDA’s ability to 
protect the food supply. 
 116. For example, the FDA has recognized that lead can contaminate candies 
eaten by children and has set limits as to the maximum amount permitted (1 part 
per million). See, e.g., U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG 
ADMIN., GUIDANCE FOR INDUSTRY: LEAD IN CANDY LIKELY TO BE CONSUMED 
FREQUENTLY BY SMALL CHILDREN (2006); U.S. DEP’T OF HEALTH & HUMAN SERVS., 
FOOD & DRUG ADMIN., SUPPORTING DOCUMENT FOR RECOMMENDED MAXIMUM 
LEVEL FOR LEAD IN CANDY LIKELY TO BE CONSUMED FREQUENTLY BY SMALL 
CHILDREN (2006); U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN., 
GUIDANCE FOR INDUSTRY: LETTER TO MANUFACTURERS, IMPORTERS, AND 
DISTRIBUTORS OF IMPORTED CANDY AND CANDY WRAPPERS (1995); see also U.S. 
DEP’T OF HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN., FOOD DEFENSE 
GUIDANCE DOCUMENTS & REGULATORY INFORMATION (2017) (collecting 
memoranda and information); U.S. DEP’T OF HEALTH & HUMAN SERVS., FOOD & 
DRUG ADMIN., MITIGATION STRATEGIES TO PROTECT FOOD AGAINST INTENTIONAL 
ADULTERATION: WHAT YOU NEED TO KNOW ABOUT THE FDA REGULATION: 
GUIDANCE FOR INDUSTRY SMALL ENTITY COMPLIANCE GUIDE (2017); U.S. DEP’T OF 
HEALTH & HUMAN SERVS., FOOD & DRUG ADMIN., CNTR. FOR DRUG EVALUATION AND 
RESEARCH, CNTR. FOR BIOLOGICS EVALUATION AND RESEARCH, GUIDANCE FOR 
INDUSTRY, WARNINGS AND PRECAUTIONS, CONTRAINDICATIONS, AND BOXED 
WARNING SECTIONS OF LABELING FOR HUMAN PRESCRIPTION PRODUCTS AND 
BIOLOGICAL PRODUCTS—CONTENT AND FORMAT (2011). If the FDA were to find 
that THC-infused food products are “adulterated” or “misbranded” under the 
FDCA, the FDA could take action against edibles. Or if the FDA found that there 
is a public health risk that accidentally ingested edibles would harm minors, the 
FDA could act to protect minors from those products. 
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instances in which it has found one federal statute to repeal 
another by implication “is due to the relatively stringent 
standard” for reaching that conclusion—namely, that there 
is “an irreconcilable conflict” or “positive repugnancy” 
between the two laws.117 That is not the case here. As a 
result, “when two statutes are capable of coexistence,” as 
these two are, “it is the duty of the courts, absent a clearly 
expressed congressional intention to the contrary, to regard 
each as effective.”118 
Broadly construing the Rohrabacher rider would lead to 
results that Congress clearly did not intend. There is scant 
evidence that Congress wanted to disable the FDA from 
preventing the public from being injured by a large batch of 
edibles that became adulterated from a toxin or other 
hazardous substance, whether due to the intentional 
misconduct of an officer or employee of the firm that 
manufactured the items, or due to the reckless or even 
negligence conduct of employees on the “assembly line” so to 
speak. Yet, a broad interpretation of the rider would deny the 
FDA the ability to use its legal authority to prevent 
undeniable harm to the consuming public. Congress did not 
intend that anomalous result, and the rider does not demand 
that the FDA stand aside and allow it to occur. For that 
reason, it would make no sense to construe the rider to 
prevent the FDA, even with the Justice Department’s 
assistance, from halting the distribution and consumption of 
food products to which someone had intentionally or 
mistakenly added a hazardous substance simply because the 
edibles also contained THC. If so, the result should be no 
different if the FDA deems THC itself to be an adulterant, 
given its potentially harmful effects on adults and minors. 
 
 117. J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred Int’l., Inc., 534 U.S. 124, 142–
43 (2001). 
 118. Id. at 143–44; see also POM Wonderful LLC v. Coca-Cola Co., 134 S. Ct. 
2228, 2238 (2014). 
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IV. THE OPTIONS OPEN TO THE FDA AND JUSTICE 
DEPARTMENT 
The FDA and Justice Department have the power to halt 
or regulate the distribution of marijuana edibles. They also 
have a range of options to pursue. What should they do? The 
next subsections discuss those possibilities. 
A. An Aggressive Approach 
One option is for the FDA and Justice Department to 
aggressively enforce federal law in every fashion that the 
federal code allows. The agencies could undertake a full-bore 
attack on the sale of medical and recreational marijuana, 
including edibles, in states where they have been legalized. 
Federal law enforcement officers could seize any and all 
marijuana sold by brick-and-mortar dispensaries or online, 
along with whatever cannabis is grown for commercial sale, 
as well as arrest the parties who played a material role in a 
distribution program. The Justice Department could bring 
criminal charges against individuals for growing marijuana, 
for manufacturing cannabis products, and for distributing 
both. The department could prosecute the distribution 
businesses in states like California and Colorado under the 
federal controlled substances laws, as well as pursue the full 
range of ancillary offenses that large-scale marijuana 
distribution businesses might commit, such as racketeering 
and money laundering.119 The FDA could complement the 
work of the Justice Department by initiating the 
administrative seizure of marijuana edibles on the ground 
that they are adulterated and misbranded foods. Together, 
the Justice Department and the FDA could close businesses 
engaged in the commercial distribution of cannabis, deter 
 
 119. Money Laundering Control Act of 1986, Pub. L. No. 99-570, 100 Stat. 3207 
(1986) (codified at 18 U.S.C. 1956–1957 (2012)); Racketeer Influenced and 
Corrupt Organizations Act, enacted as § 901(a) of the Organized Crime Control 
Act of 1970, Pub. L. No. 91-452, 84 Stat. 922 (codified at 18 U.S.C. §§ 1961–1968 
(2012)). 
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other entrepreneurs from opening new operations, and 
effectively dissuade investors from seeking to underwrite 
this business. 
Those agencies might be willing to go forward with that 
approach if three conditions were true: (1) they believed that 
it is legally authorized, (2) they believed that it is a sensible 
use of federal resources, and (3) they could count on the 
support of the White House and Congress.120 It is unlikely 
that the Justice Department and FDA will select that option, 
however, for several reasons. 
A full-frontal assault on the state liberalization schemes 
would likely ignite a challenging political battle between the 
states and members of Congress on one side and the 
Executive Branch on the other. At present, more than forty 
states and the District of Columbia allow marijuana itself or 
one of its constituents to be used for medical purposes.121 
States could enlist the support of a large majority of the 
Senate along with the representatives from the relevant 
states, one of which is California, which alone has fifty-three 
members of the House. For public and media support, those 
states and the members of Congress would showcase the 
patients who use some form of marijuana to alleviate their 
suffering as they cross the River Styx, as well as the 
children—and their parents—who use marijuana to deal 
with seizures.122 Indeed, the pictures of patients being 
 
 120. Cf. Cully Stimson, How Trump’s DOJ Can Start Enforcing Federal 
Marijuana Law, DAILY SIGNAL (Feb. 27, 2017), http://dailysignal.com/2017/02/27/
how-trumps-doj-can-start-enforcing-federal-marijuana-law/. 
 121. NAT’L ACAD. REP., supra note 5, at 68 & Fig. 3-1, 74; Kosa et al., supra note 
15, at 57. 
 122. See, e.g., Colorado Girl Sues Jeff Sessions to Legalize Medical Marijuana 
Nationwide, FOX NEWS (Nov. 12, 2017), http://www.foxnews.com/us/2017/11/12/
colorado-girl-sues-jeff-sessions-to-legalize-medical-marijuana-nationwide.html. 
(“A Colorado girl [Alexis Bortell] who suffers from seizures joined a lawsuit to sue 
U.S. Attorney General Jeff Sessions in a bid to legalize medical marijuana 
nationwide. Alexis Bortell, 12, told FOX31 Denver she was diagnosed with 
epilepsy and traditional medicine wasn’t helping her seizures. Her doctors in 
Texas recommended an invasive brain surgery, but a pediatrician suggested 
medical marijuana. . . . Bortell found that taking a drop of Haleigh’s Hope, a 
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replayed on television over and over would probably carry 
more weight in the court of public opinion than what the 
members of Congress can bring to bear. 
Attorney General Sessions may be willing to trigger a 
large-scale controversy, but it is not clear that President 
Trump is. In fact, the president has been noticeably quiet 
about marijuana legalization since being sworn into office. 
Moreover, the Trump Administration does not yet have in 
office a Director of the Office of National Drug Control 
Policy—the person who is responsible for developing, 
coordinating, and articulating the nation’s response to drug 
problems. Trying to move forward on this issue without an 
appointee in that office would be like trying to move the ball 
downfield without a quarterback. 
There is an odd feature of our current marijuana 
regulatory scheme resulting from the federalist nature of our 
system of government. States, like Colorado, have 
established state bureaus to regulate the distribution of 
medical and recreational marijuana, which includes 
approving businesses that may sell cannabis products.123 
Federal law enforcement officials might be willing to shut 
down the private retail sale of marijuana, but they would be 
quite reluctant to prosecute state officials for implementing 
a program required by state law.124 Charging state 
 
strain of cannabis oil, twice a day prevented the seizures from coming back. She’s 
been seizure-free for nearly three years, but she can’t return to Texas because 
marijuana is illegal there. Colorado is one of several states that legalized 
marijuana for medicinal and recreational use.”). 
 123. In Colorado, the Marijuana Enforcement Division of the Colorado 
Department of Revenue is responsible for regulating medical and retail 
marijuana. See COLO. CODE REGS. § 212-1 (2017) (medical marijuana rules); id. § 
212-2 (retail marijuana rules); COLO. DEP’T REVENUE, ENFORCEMENT DIV., 
MARIJUANA (2017), https://www.colorado.gov/pacific/enforcement/marijuana
enforcement. In Washington, the Liquor and Cannabis Board has that 
responsibility. See WASH. REV. CODE § 66.08.012 (2017); WASH. ADMIN. CODE § 
314-55 (2017). 
 124. State and local law enforcement personnel are exempt from federal 
criminal liability if they are “lawfully engaged in the enforcement of any law or 
municipal ordinance relating to controlled substances.” 21 U.S.C. § 885(d) (2012). 
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regulators would raise novel questions of “causation” in the 
criminal law that the courts might decide against the 
department.125 In any event, doing so would quite naturally 
chill the relationship between federal law enforcement 
officers and their state or local counterparts. Neither the 
Justice Department nor the Department of Homeland 
Security, nor their constituent agencies—such as the Federal 
Bureau of Investigation, the Drug Enforcement 
Administration, and the U.S. Secret Service—want to see 
that happen. Federal law enforcement officers—especially 
the Secret Service—partner with state and local 
departments in a host of different matters, such as offering 
security for the president whenever he leaves the White 
House. If, in response to federal prosecution of state officials, 
states and localities were to decline to assist federal law 
enforcement agencies, the latter would be severely hampered 
in their effectiveness to enforce federal law. Accordingly, the 
federal government might not want to prosecute state 
 
That provision appears directed at the situation in which state or local officers 
take possession of a controlled substance during a search or seizure undertaken 
to enforce state criminal law. Efforts to ensure the distribution of marijuana 
under a state medical or recreational program would not qualify under that 
exemption. See United States v. Rosenthal, 266 F. Supp. 2d 1068, 1079 (N.D. Cal. 
2003) (“‘[L]awfully engaged” in “enforcing a law related to controlled substances” 
must mean engaged in enforcing, that is, compelling compliance with, a law 
related to controlled substances which is consistent . . . or at least not 
inconsistent . . . with the Controlled Substances Act. Section 885(d) cannot 
reasonably be read to cover acting pursuant to a law which itself is in conflict 
with the Act.”), aff’d 454 F.3d 943, 948 (9th Cir. 2006) (“We agree with the district 
court that cultivating marijuana for medical use does not constitute ‘enforcement’ 
within the meaning of § 885.”). 
 125. See 18 U.S.C. § 2 (2012) (someone who causes someone else to commit a 
crime is responsible for that crime). Aside from raising proximate cause issues 
that would exceed the ones discussed in Palsgraf v. L.I.R.R. Co., 162 N.E. 99 (N.Y. 
1928), the prosecution of state officials, not for the commercial distribution of 
marijuana, but for regulating that activity, might be the push that the Supreme 
Court needs to finally adopt a mistake of law defense. See, e.g., Paul J. Larkin, 
Jr., The Folly of Requiring Complete Knowledge of the Criminal Law, 12 LIBERTY 
U. L. REV. (forthcoming 2018); Edwin Meese III & Paul J. Larkin, Jr., 
Reconsidering the Mistake of Law Defense, 102 J. CRIM. L. & CRIMINOLOGY 725 
(2012). 
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officials for doing their jobs.126 
Focusing on recreational marijuana use is also likely to 
be more socially valuable because recreational use programs 
present a greater risk of encouraging teenagers to try 
marijuana. Limiting marijuana use to terminally ill patients 
or people suffering from painful, disabling diseases does not 
necessarily weaken the stigma associated with marijuana 
use or undermine the message that marijuana is a harmful 
drug; the message sent by a medical use program can readily 
be seen as one of compassion.127 By contrast, a recreational 
 
 126. Of course, if the Justice Department were not to bring charges against 
state parties, the private defendants in marijuana cases would doubtless claim 
that the federal government had irrationally discriminated against them by not 
granting them the same leniency that state officials received. The litigation over 
those claims would take years to resolve. The result is that, if the Justice 
Department seeks to end both state medical and recreational marijuana 
programs, the Justice Department cannot make a decision that does not have a 
serious downside to it. 
 127. The Substance Abuse and Mental Health Administration, an arm of the 
U.S. Department of Health and Human Services, has found that teenage 
marijuana use has increased in Colorado but not in Washington from 2011–2015. 
See U.S. DEP’T OF HEALTH & HUMAN SERVS., SUBSTANCE ABUSE & MENTAL HEALTH 
SERVS. ADMIN., HHS Publication No. SMA–17–Baro–16–States–CO (2017) (“In 
Colorado, an annual average of about 46,000 adolescents aged 12–17 (11.1% of 
all adolescents) in 2014–2015 used marijuana in the past month. The annual 
average percentage in 2014–2015 was not significantly different from the annual 
average percentage in 2011–2012.”); U.S. DEP’T OF HEALTH & HUMAN SERVS., 
SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., HHS Publication No. SMA–
17–Baro–16–States–WA (2017) (“In Washington, an annual average of about 
49,000 adolescents aged 12–17 (9.2% of all adolescents) in 2014–2015 used 
marijuana in the past month. The annual average percentage in 2014–2015 was 
not significantly different from the annual average percentage in 2011–2012.”). 
Other studies have differed as to whether recreational marijuana laws lead to 
increased marijuana use, particularly by minors. Most have found no such effect. 
See, e.g., CAULKINS ET AL., MARIJUANA LEGALIATION, supra note 5, at 213; Esther 
K. Choo et al., The Impact of State Medical Marijuana Legislation on Adolescent 
Marijuana Use, 55 J. ADOLESCENT HEALTH 160 (2014); Sam Harper et al., Do 
Medical Marijuana Laws Increase Marijuana Use? Replication Study and 
Extension, 22 ANNALS EPIDEMIOLOGY 207 (2012); Deborah S. Hasin et al., Medical 
Marijuana Laws and Adolescent Marijuana Use in the USA from 1991 to 2014: 
Results from Annual, Repeated Cross-Sectional Surveys, 2 LANCET PSYCHIATRY 
601, 601 (2015); Julie Johnson et al., The Design of Medical Marijuana Laws and 
Adolescent Use and Heavy Use of Marijuana: Analysis of 45 States from 1991 to 
2011, 170 DRUG & ALCOHOL DEPENDENCE 1, 6–7 (2017) (all concluding that state 
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use program sends the message to minors that marijuana is 
the same as alcohol, something reserved for adults and not 
harmful when used in moderation. Studies also differ on the 
question of whether medical marijuana programs encourage 
teen use of cannabis; some say “yes,” others “no.” Yet, studies 
of medical marijuana programs “cannot be generalized to 
laws on recreational use,” according to the American Medical 
Association, because recreational-use laws “may have much 
broader effects through such factors as pricing, advertising, 
availability, and/or implicit messages to teens that 
marijuana use is acceptable or nonrisky.”128 
A 2017 study published in the Journal of the American 
Medical Association Pediatrics, however, found empirical 
 
medical marijuana laws did not cause an increase in youth marijuana use); D. 
Mark Anderson et al., Medical Marijuana Laws and Teen Marijuana Use 19–20 
(Nat’l Bureau Econ. Research, Working Paper No. 20332). A few have found an 
effect. See, e.g., Lisa Stolzenberg et al., The Effect of Medical Cannabis Laws on 
Juvenile Cannabis Use, 27 INT’L J. DRUG POL’Y 82, 82 (2016) (surmising that state 
medical marijuana laws spur increased marijuana use by juveniles by reducing 
the social stigma from its use); Melanie M. Wall et al., Adolescent Marijuana Use 
from 2002 to 2008: Higher in States with Medical Marijuana Laws, Cause Still 
Unclear, 21 ANN. EPIDEMIOLOGY 714, 715–16 (2011) (noting increase but not 
attributing a cause); cf. Katherine M. Keyes et al., How Does State Marijuana 
Policy Affect US Youth? Medical Marijuana Laws, Marijuana Use and Perceived 
Harmfulness: 1991–2014, 111 ADDICTION 2187, 2192 (2016) (concluding that the 
passage of state medical marijuana laws is associated with “increases in 
perceived harmfulness amount youth and that marijuana use has decreased 
among youth with that view”); Rosalie L. Pacula et al., Assessing the Effects of 
Medical Marijuana Laws on Marijuana Use: The Devil Is in the Details, 34 J. 
POL’Y ANALYSIS & MGT. 7, 29 (2015) (concluding that states with marijuana 
dispensaries protected by state law may see an increase in marijuana use by 
adults and minors); see generally CAULKINS ET AL., MARIJUANA LEGALIATION, supra 
note 5, at 212 (“There are now enough contradictory published findings that 
advocates on any side can weave whatever story they will to tell.”). But see JT 
Borodovsky et al., U.S. Cannabis Legalization and Use of Vaping and Edible 
Products Among Youth, 177 DRUG & ALCOHOL DEPENDENCE 299, 305 (2017) (the 
effect of marijuana legalization on use by minors may vary according to the 
statute at issue); Wayne Hall & Michael Lynskey, Why It Is Probably Too Soon 
to Assess the Public Health Effects of Legislation of Recreational Cannabis Use in 
the USA, 3 LANCET PSYCHIATRY 900, 900, 904 (2016) (concluding that the current 
short-term studies of recreational cannabis use may not predict the long-term 
results given several identified but unanswered questions). 
 128. Cerdá et al., supra note 4, at 143. 
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support for the belief that recreational marijuana laws can 
encourage minors to use marijuana.129 The study found that 
Washington State had seen a rise in recreational marijuana 
use by minors after adults were permitted to use marijuana 
recreationally in 2012.130 Colorado did not see the same 
increase in minors’ use of cannabis once its recreational 
program went into effect, the study found,131 but it concluded 
that recreational marijuana laws, however, may pose a 
greater risk in that regard.132 The upshot is that 
 
 129. See id. at 148. 
 130. The study noted: 
The post-RML increase in adolescent marijuana use in Washington 
could have several explanations. First, our findings suggest that 
legalization of recreational marijuana use in 2012 reduced stigma and 
perception of risk associated with marijuana use. A shift in social norms 
regarding marijuana use may have, in turn, increased marijuana use 
among adolescents in Washington. Second, legalization may have 
increased availability, increasing adolescent access to marijuana 
indirectly through third-party purchases. Third, legalization could have 
decreased the price of marijuana in the black market, particularly after 
the first grower licenses in Washington were issued in March 2014 and 
the first stores opened in July 2014. . . . Fourth, the increase in 
marijuana use observed in Washington could be due to other changes 
occurring at the same time as RML rather than to RML itself. 
Id. at 146–47 (footnotes omitted). 
 131. See id. at 147–48. 
 132. The study noted: 
This difference may be related to the different degree of 
commercialization prior to [recreational] legalization in Washington and 
Colorado. Colorado had a very developed medical marijuana dispensary 
system prior to legalization, with substantial advertising, to which youth 
were already exposed. Washington, on the other hand, did not provide 
legal protection to medical marijuana stores. Therefore, the degree of 
commercialization and advertising of these collectives was substantially 
lower than in Colorado. In addition, rates of perceived harmfulness in 
Colorado were already lower than rates in Washington and non-RML 
[recreational marijuana law] states prior to legalization. Preexisting low 
levels of perceived harmfulness and high levels of use may have 
constrained further short-term increases following RML enactment. The 
longer-term effect of RML implementation on adolescent marijuana use 
in Colorado is still to be determined. 
Id. at 147–48 (footnotes omitted). 
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recreational-use laws may lead to greater marijuana use by 
adults and minors both by not only diminishing—or 
eliminating—the stigma associated with marijuana use, but 
also reducing the price of cannabis by increasing its 
supply.133 
There are, however, less aggressive steps that the FDA 
and Justice Department can take. 
B. A Cautious Approach 
If the federal government concludes that challenging 
medical use of marijuana would generate overwhelming 
political opposition, there are smaller steps that the Justice 
Department could take. To start with, it could focus on the 
state laws authorizing the recreational use of marijuana. To 
narrow its focus even further, the government could also 
address the risk that marijuana sold for recreational use 
could wind up being used by minors, to their detriment. That 
would particularly be true in the case of any edible that 
closely resembles—or could be mistaken by a minor to be—
candy. The government, therefore, could seek to prevent the 
distribution of all edibles or only the ones that could readily 
be mistaken for ordinary candy or a similar item. Finally, 
rather than bring a criminal prosecution against individuals 
or businesses for the sale of edibles, at least as a first step, 
the Justice Department could enlist the support of the FDA 
and seize adulterated edibles. 
If the department decides to proceed in this manner, the 
scenario could play out in two steps. Step one would be for 
the FDA to declare that the addition of THC to any edible 
renders the product “adulterated” under the FDCA. Step two 
would be to initiate the seizure of any edible products offered 
for retail sale.134 Given the popularity of edibles, those steps 
 
 133. Id. at 146–47; see also Wayne Hall & Michael Lynskey, Evaluating the 
Public Health Impacts of Legalizing Recreational Cannabis Use in the United 
States, 111 ADDICTION 1764, 1766 (2016). 
 134. See 21 U.S.C. § 334(g), (h) (authorizing the temporary administrative 
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would have the short-run effect of reducing the supply of 
THC, halving the profits from the sale of medical and 
recreational marijuana, increasing the price of the smoked 
form of marijuana, and driving people, adults and minors, 
toward the comparatively more dangerous practice of 
smoking cannabis.135 Or, the FDA could take two smaller 
steps: (1) forbidding the sale of edibles that a reasonable 
person could confuse with a legitimate baked good, candy, or 
anything similar; and (2) requiring the packaging and sale of 
any other edible to satisfy a list of requirements deemed 
necessary to reduce the risk that children will accidentally 
ingest that product. Those requirements could include the 
demands that the states already place on the sale of 
marijuana—such as the limitation to designated retail 
outlets of distribution rights, the use of child-proof 
packaging, and the imposition of labeling dictates that 
clearly display the contents on the package and warn against 
the potential consequences of use.136 
There is precedent for the FDA to intervene in the sale 
of marijuana products. On October 31, 2017, as part of its 
“ongoing efforts to protect consumers from health fraud,” the 
FDA issued a warning letter to four large companies selling 
for the treatment of various diseases self-labeled dietary 
supplements products containing cannabidiol, a non-
 
detention of adulterated foods without a hearing); Ewing v. Mytinger & 
Casselberry, Inc., 339 U.S. 594 (1950) (rejecting a Due Process Clause challenge 
to the FDA’s authority to seize adulterated or misbranded food before a judicial 
hearing on the FDA’s claim is held). 
 135. See supra note 11. 
 136. A more aggressive position would be to require states that want to sell 
edibles to do so only from state owned and operated facilities. Some states have 
that requirement for the sale of distilled spirits, so the concept is not a new one. 
See, e.g., VA. CODE ANN. § 4.1-100 (2017) (defining “Alcohol,” “Alcoholic 
beverages,” “Beer,” “Spirits,” and “Wine”); id. § 4.1-101 (creating the Virginia 
Alcoholic Beverage Control Authority); id. § 4.1-103 (empowering the Board of 
Directors of the Virginia Alcoholic Beverage Control Authority to sell distilled 
spirits). No state currently follows that option so they would need to enact new 
laws to govern the sale of edibles. Whether the federal government should 
exercise its prosecutorial discretion to force the states to choose that option and 
whether states should independently adopt it are beyond the scope of this Article. 
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psychoactive substance found in marijuana that the FDA has 
not approved for use in any drug for any purpose.137 In each 
case, the FDA found that the company marketed a new drug 
without prior FDA approval, as required by the FDCA, and 
misbranded the drugs by claiming that they can be used for 
the treatment of disease. The FDA took this action, as FDA 
Commissioner Scott Gottlieb explained in an accompanying 
press release, to protect cancer patients against companies 
“that deliberately prey on sick people with baseless claims 
that their substance can shrink or cure cancer.”138 
 
 137. See FDA Warning Letter from Maridalia Torres-Irizarry, San Juan Dist. 
Dir., FDA, to Laura Fuentes, Green Roads of Florida LLC (Oct. 31, 2017), 
https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2017/ucm5831
88.htm; FDA Warning Letter from Darla Bracy, L.A. Dist. Dir., FDA, to Will 
Claren, CEO, Natural Alchemist (Oct. 31, 2017), https://www.fda.gov/ICECI/
EnforcementActions/WarningLetters/2017/ucm583205.htm; FDA Warning 
Letter from CDR Steven E. Porter, Jr., L.A. Dist. Dir., FDA, to Joel Stanley, CEO, 
Stanley Brothers Social Enterprises, LLC (Oct. 31, 2017), https://www.fda.gov/
ICECI/EnforcementActions/WarningLetters/2017/ucm583192.htm [hereinafter 
Stanley Bros. FDA Letter]; FDA Warning Letter from CDR Steven E. Porter, Jr., 
L.A. Dist. Dir., FDA, to Tisha T. Casida, That’s Natural! Marketing and 
Consulting (Oct. 31, 2017), https://www.fda.gov/ICECI/EnforcementActions/
WarningLetters/2017/ucm583197.htm. 
 138. The FDA said in a 2017 press release: 
‘Substances that contain components of marijuana will be treated like 
any other products that make unproven claims to shrink cancer tumors. 
We don’t let companies market products that deliberately prey on sick 
people with baseless claims that their substance can shrink or cure 
cancer and we’re not going to look the other way on enforcing these 
principles when it comes to marijuana-containing products,’ said FDA 
Commissioner Scott Gottlieb, M.D. ‘There are a growing number of 
effective therapies for many cancers. When people are allowed to 
illegally market agents that deliver no established benefit they may 
steer patients away from products that have proven, anti-tumor effects 
that could extend lives. . . . We have an obligation to provide caregivers 
and patients with the confidence that drugs making cancer treatment 
claims have been carefully evaluated for safety, efficacy, and quality, 
and are monitored by the FDA once they’re on the market,’ 
Commissioner Gottlieb added. ‘We recognize that there’s interest in 
developing therapies from marijuana and its components, but the safest 
way for this to occur is through the drug approval process—not through 
unsubstantiated claims made on a website. We support sound, 
scientifically-based research using components derived from marijuana, 
and we’ll continue to work with product developers who are interested 
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A Colorado company, for example, used an Internet 
website to sell products that it claimed can be used in the 
treatment of cancer, Alzheimer’s, diabetes, Chronic 
Traumatic Encephalopathy, and other diseases, as well as 
for pain relief.139 The FDA concluded that the products are 
“drugs” for purposes of the FDCA because they are used “in 
the diagnosis, cure, mitigation, treatment, or prevention of 
disease and/or are intended to affect the structure of any 
function in the body.”140 The products also did not fit within 
the exception for dietary supplements because that exception 
is unavailable when there are authorized clinical 
investigations underway for the product, and two such 
investigations are in progress for drugs containing 
cannabidiol.141 The products, according to the FDA, are also 
not generally recognized as safe and effective and therefore 
are “new drugs” for purposes of the FDCA, which cannot be 
introduced into interstate commerce without prior FDA 
approval.142 
Moreover, the FDA also concluded that the products 
were “misbranded” under the FDCA. The FDCA deems a 
drug misbranded unless there are adequate directions for its 
 
in bringing safe, effective, and quality products to market.’ 
Press Release, FDA, FDA Warns Companies Marketing Unproven Products, 
Derived from Marijuana, that Claim to Cure or Treat Cancer (Nov. 1, 2017), 
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583295.
htm); see also, e.g., Anna Edney & Jenifer Kaplan, FDA Cracks Down on 
Marijuana Cancer Treatment Claims, BLOOMBERG TECH. (Nov. 1, 2017), 
https://www.bloomberg.com/news/articles/2017-11-01/fda-cracks-down-on-medic
al-marijuana-cancer-treatment-claims; Sheila Kaplan, F.D.A Warns Companies 
Against Claims that Marijuana Cures Diseases, N.Y. TIMES (Nov. 1, 2017), 
https://www.nytimes.com/2017/11/01/health/fda-marijuana-false-claims.html; 
Mina Zhang, FDA Targets Country’s Largest Cannabidiol Producer in Warning 
over Cancer Claims, FORBES (Nov. 1, 2017), https://www.forbes.com/
sites/monazhang/2017/11/01/the-fda-targets-countrys-largest-cbd-producer-in-
warning-over-cancer-claims/#3fff46493fb7. 
 139. See Stanley Bros. FDA Letter, supra note 137. 
 140. Id. 
 141. Id. 
 142. Id. (citing 21 U.S.C. § 321(p)). 
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intended use—that is, directions a layperson can understand 
to use a drug safely and effectively.143 In the case of a 
prescription drug, the FDA has concluded that it can be used 
safely only at the direction and under the supervision of a 
licensed physician.144 The diseases at issue are ones that 
cannot be diagnosed or treated without the supervision of a 
licensed physician, which an Internet purchase does not 
require. Moreover, it is legally impossible for a layperson to 
write adequate directions for someone to use the company’s 
drugs safely and effectively to treat those diseases.145 The 
FDA therefore directed the company to correct the violations 
or face legal action, which could include seizure of the 
relevant products and an injunction against further 
distributions.146 
Ordinarily, it might make sense for the federal 
government to leave to the states the freedom to experiment 
with various regulatory regimes. States can then experiment 
with different solutions to the problems discussed in this 
Article. Insofar as those problems are due to use of edibles by 
“marijuana tourists,” publicity might be a more efficient way 
to prevent misuse. The states have regulations for edibles, 
although they vary widely.147 Those factors argue in favor of 
deferring a uniform, federal solution for any problems until 
more evidence is in. At the same time, what those regulations 
cover and how seriously they are applied might be open 
questions, or at least subject to dispute. Some states might 
be acting responsibly.148 Some states, however, have created 
 
 143. Id. (citing 21 U.S.C. §§ 352(f)(1) and 21 C.F.R. § 201.5 (2017)). 
Recommendations by a “barista” at the local cannabis store would not qualify. 
 144. Id. (citing 21 U.S.C. § 353(b)(1)(A)). 
 145. Id. 
 146. Id. 
 147. Barrus et al., supra note 11, at 9 (“[C]urrently, the rules governing the 
manufacturing and labeling of edibles varies dramatically from state to state.”); 
see also, e.g., id. at 9–10. 
 148. See CAULKINS ET AL., MARIJUANA LEGALIATION, supra note 5, at 204 (“So as 
a gross generalization, medical-marijuana regimes created by state legislatures 
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medical marijuana programs that are effectively recreational 
marijuana programs under a different name.149 
What ultimately militates in favor of the FDA’s 
intervention is this: Congress chartered the FDA to protect 
the nation’s food supply by intervening where necessary to 
prevent the distribution of adulterated foods. If the FDA 
concludes that the addition of THC to a food product renders 
it adulterated, there is no reason why the FDA should defer 
to whatever answer the states offer on that subject. 
Accordingly, if the Justice Department agrees to defend the 
FDA’s legal position in court, there is no sound reason for the 
FDA to forego enforcing the FDCA against marijuana 
edibles. Federalism principles do not require the FDA to 
stand aside and watch as adulterated edibles are sold. 
Moreover, three related statutes are instructive here. 
The first one is the Cigarette Labeling and Advertising Act 
 
east of the Mississippi generally appear to be good-faith efforts to provide 
compassionate access to people with well-defined conditions, while regimes 
originally created by voter propositions farther west are extremely permissive 
and easy to manipulate.”). 
 149. See id. at 511 nn.275, 277 & 279; Larkin, supra note 4, at 511–12 (“There 
is considerable proof that many state medical marijuana programs are simply a 
sham for the decriminalization of that substance. Consider the following: 
according to a 2013 study, in Arizona merely seven of 11,186 applications for 
medical marijuana had been denied. Only 2,000 patients registered for Colorado’s 
medical marijuana program before the Justice Department announced in 2009 
that it would not enforce the federal marijuana laws against individual patients 
and caregivers. Colorado residents apparently listened because by March 2011, 
there were more than 127,000 Colorado registrants. In Colorado, fewer than 
fifteen physicians wrote more than seventy percent of all medical marijuana 
recommendations, with the reason being severe or chronic pain in ninety-four 
percent of the reported conditions. Michigan had fifty-five physicians certify 
approximately 45,000 patients. California does not require patients to register to 
receive marijuana for medical use, so the number of patients is a matter of 
speculation. Estimates, however, are that the number increased from 30,000 in 
2002 to more than 300,000 in 2009 and 400,000 in 2010. The California statute 
permits a patient or caregiver to possess six plants, but it allows counties to 
amend state guidelines. Humboldt County, which lies in the heart of the 
Northern California marijuana farming, allows resident to grow up to ninety-
nine plants on behalf of a patient. Not surprisingly, there is also considerable 
evidence that significant quantities of marijuana grown or sold for medical uses 
have been diverted for recreational use.”) (footnotes omitted). 
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(CLAA).150 The act states that it is federal policy “to establish 
a comprehensive Federal program to deal with cigarette 
labeling and advertising with respect to any relationship 
between smoking and health.”151 The goals are to ensure that 
“the public may be adequately informed about any adverse 
health effects of cigarette smoking by inclusion of warning 
notices on each package of cigarettes and in each 
advertisement of cigarettes” and to prevent “diverse, 
nonuniform, and confusing cigarette labeling and 
advertising regulations with respect to any relationship 
between smoking and health” from impeding the national 
economy.152 To reach those goals, the act empowers the 
Secretary of Health and Human Services (HHS) to 
promulgate advertising requirements for cigarette 
packaging.153 The second law is the Nutrition Labeling and 
Education Act of 1990 (NLEA).154 It empowers the HHS 
Secretary to promulgate nutritional labeling requirements 
for commercial food products.155 The third statute is the 
Poison Prevention Packaging Act of 1970 (PPPA).156 It 
requires use of child-resistant packaging for prescription 
drugs, over-the-counter drugs, household chemicals, and 
other hazardous materials potentially dangerous to children. 
The statute empowers the Consumer Product Safety 
Commission (CPSC) to establish “technically feasible, 
 
 150. Pub. L. No. 88-92, 79 Stat. 282 (1965) (codified as amended at 15 U.S.C. 
§§ 1333–41 (2012)). 
 151. Federal Cigarette Labeling and Advertising Act, 15 U.S.C. § 1331 (2012). 
 152. Id. § 1331(1)–(2). 
 153. See id. § 1333. The CLAA also leaves in place the Federal Trade 
Commission’s authority to take action against unfair or deceptive acts or 
practices regarding cigarette advertising. Id. § 1336. 
 154. Pub. L. No. 101-535, 104 Stat. 2353 (codified as amended at 21 U.S.C. §§ 
321, 337, 343, 343-1, 345, 371 (2012)). The NLEA amended the FDCA. See § 1(b), 
104 Stat. at 2353. 
 155. See § 2, 104 Stat. at 2353–57 (codified as amended at 21 U.S.C. § 343(q) 
(2012)). 
 156. Pub. L. No. 91-601, 84 Stat. 1670 (codified as amended at 15 U.S.C. §§ 
1471–77 (2012)). 
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practicable, and appropriate” packaging standards for “any 
household substance” if it found that doing so was necessary 
“to protect children from serious personal injury or serious 
illness resulting from handling, using, or ingesting” that 
substance.157 In particular, the CPSC can prohibit the use of 
packages “which it determines are unnecessarily attractive 
to children.”158 The PPPA defines a “household substance” to 
include “any substance” that is “customarily produced or 
distributed for sale for consumption or use, or customarily 
stored, by individuals in or about the household and which 
is . . . a food as defined in” the FDCA.159 That definition 
would include marijuana edibles. 
Rather than leave the matter to the states, Congress 
enacted those laws to empower the federal government to 
establish national packaging and labeling standards for 
items such as food, cigarettes, and household cleaning 
products to inform adult consumers what they were 
voluntarily or accidentally ingesting and to prevent minors 
from mistakenly consuming such products. In each case, 
Congress also directed a federal agency to develop the 
nationwide rules.160 The statutes therefore evince the 
judgment that it is a national responsibility to protect the 
public against the knowing or mistaken ingestion of 
potentially harmful substances. Those policy choices are 
 
 157. Poison Prevention Packaging Act of 1970, 15 U.S.C. § 1472(a)(1)–(2) 
(2012). 
 158. Id. § 1472(d). 
 159. Id. § 1471(2)(B). 
 160. A Memorandum of Understanding (MOU) between the FDA and the 
CPSC recognized that the CPSC has the primary responsibility for regulating 
food containers, but reserves the FDA’s right to regulate containers insofar as 
there is a migration of particles from the container into the food or the container 
is composed, in whole or in part, of a poisonous or deleterious substance that 
might injure someone’s health. See U.S. FOOD & DRUG ADMIN., MOU 225-76-2003, 
MEMORANDUM OF UNDERSTANDING BETWEEN THE U.S. CONSUMER PRODUCT SAFETY 
COMMISSION AND THE U.S. FOOD AND DRUG ADMINISTRATION (1976). The MOU 
recognizes that the FDA and CPSC share responsibility for making sure that food 
containers do not injure a consumer’s health. The FDA and CPSC could negotiate 
a similar agreement over the proper regulation of the packaging of edibles. 
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entitled to respect. 
CONCLUSION 
Contemporary American society has decided that, 
whatever may be the benefits and harms of liberalizing 
marijuana use by adults, we should continue to outlaw the 
sale of recreational-use marijuana to children and 
adolescents. Even the states that permit recreational 
marijuana use under state law draw the line between adults 
and minors. Unfortunately, some companies pay only lip 
service to that line. The ability to develop products that 
closely resemble cookies, brownies, candies, and other 
substances that are attractive to children and adolescents—
albeit, for different reasons—poses the risk that minors—
some accidentally, some intentionally—will consume 
marijuana edibles found around the home or elsewhere. Any 
use of marijuana by children and long-term use of marijuana 
by adolescents poses health risks avoidable through federal 
prohibition or regulation of edibles. 
To avoid the danger to their health and safety, the 
Justice Department and the FDA should take steps to 
prevent adulterated and mislabeled edibles from harming 
the public. Even if the Justice Department decides not to 
challenge the state medical or recreational use programs, the 
FDA should consider treating such edibles as adulterated 
foods under the FDCA—taking whatever steps are available 
to prevent the sale of any such products altogether—or to 
allow sales to go forward only under strictly regulated 
conditions. Doing so would help to reduce the danger that 
edibles pose to the health and safety of children and 
adolescents without materially interfering in state decisions 
on how to regulate the distribution of medical-use marijuana 
or the recreational use of that drug by adults. 
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APPENDIX 
FIGURE 1. A first Marijuana Edible example.161 
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